fluoxetine has been researched along with sertraline in 494 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (0.61) | 18.7374 |
| 1990's | 165 (33.40) | 18.2507 |
| 2000's | 167 (33.81) | 29.6817 |
| 2010's | 121 (24.49) | 24.3611 |
| 2020's | 38 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Costanzo, MJ; Gardocki, JF; Maryanoff, BE; McComsey, DF; Nortey, SO; Schneider, CR; Setler, PE; Shank, RP | 1 |
| Jones, ND; Robertson, DW; Swartzendruber, JK; Wong, DT; Yang, KS | 1 |
| Carlier, PR; Lo, MM; Lo, PC; Reynolds, IJ; Richelson, E; Sharma, TA; Tatsumi, M | 1 |
| Dormann, SM; Haefeli, WE; Kerpen, CJ; Ketabi-Kiyanvash, N; Martin-Facklam, M; Weiss, J | 1 |
| Caccia, S; Casini, A; Scozzafava, A; Supuran, CT | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Buck, LB; Petrascheck, M; Ye, X | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Bush, LR; Campbell, UC; Engel, SR; Hardy, LW; Hewitt, MC; Koch, P; Ma, J; Malcolm, SC; Saraswat, LD; Schreiber, R; Shao, L; Spear, KL; Spicer, NA; Varney, MA; Wang, F | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Jung, ME; Kang, SY; Kim, HJ; Kim, J; Kim, MJ; Kim, MS; Lee, J; Lee, KN; Lee, M; Lee, SH; Park, EJ; Park, WK; Seo, HJ; Son, EJ | 1 |
| Bagale, SM; Brown, AS; Gonzalez, MM; Hentall, ID; Kumar, NS; Micotto, TL; Vitores, A; Wilson, JN | 1 |
| Fijorek, K; Glinka, A; Mendyk, A; Polak, S; Wiśniowska, B | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, L; Fei, J; Mei, Y; Ren, S; Yan, SF; Zeng, J; Zhang, JZ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Qin, W; Tian, S; Wold, EA; Xu, Q; Ye, N; Zhen, XC; Zhou, J | 1 |
| Bergmann, K; Bindman, J; Jennings, AL; Phillips, J; Seth, R | 1 |
| Bizzi, A; Caccia, S; Garattini, S; Mennini, T | 1 |
| Kriete, M; Rapoport, JL; Ryland, DH | 1 |
| Crewe, HK; Haddock, RE; Lennard, MS; Tucker, GT; Woods, FR | 1 |
| Lauder, JM; Sadler, TW; Shuey, DL | 1 |
| Brown, WA; Harrison, W | 2 |
| DeVane, CL | 1 |
| Johnson, AM; Tulloch, IF | 1 |
| Goodman, WK; McDougle, CJ; Price, LH | 2 |
| Koe, BK; Lebel, LA; Welch, WM | 1 |
| Baer, L; Buttolph, L; Holland, A; Hyman, S; Jenike, MA; Minichiello, WE; Ricciardi, J; Seymour, R; Summergrad, P | 1 |
| Rickels, K; Schweizer, E | 1 |
| Aronson, CE; Brunswick, DJ; Frazer, A; Kovachich, GB | 1 |
| Gupta, AK; Gupta, MA | 1 |
| Rothschild, AJ | 1 |
| Bryant, SG; Fisher, S; Kent, TA | 1 |
| Baumann, P; Rochat, B | 1 |
| Preskorn, SH | 4 |
| Christenson, JL; Cushing, AG; Haider, A; Miller, DR; Station, RD | 1 |
| Auerbach, SB; Rutter, JJ | 1 |
| Anelli, M; Caccia, S; Codegoni, AM; Fracasso, C; Garattini, S | 1 |
| Finley, PR | 1 |
| Hyttel, J; Sánchez, C | 1 |
| Carson, W; Jackson, C; Markowitz, J; Mintzer, J | 1 |
| Jaffe, IA | 1 |
| Goldberg, JF; Kocsis, JH; Sacks, MH | 1 |
| Schleis, T | 1 |
| Marman, GW; North, DS | 1 |
| Althof, SE | 1 |
| Helmeste, DM; Reist, C; Tang, SW; Vu, R | 1 |
| Kofoed, L; Stock, AJ | 1 |
| Greist, JH; Jefferson, JW; Katzelnick, DJ; Kobak, KA; Serlin, RC | 1 |
| Kafka, MP | 1 |
| Kaplan, PM | 1 |
| Alpert, JE; Fava, M; Maddocks, A; Rosenbaum, JF | 1 |
| Preskorn, S | 1 |
| Akpunonu, B; Grubb, BP; Kosinski, D; Samoil, D; Temesy-Armos, P | 1 |
| Deltito, JA | 1 |
| Cline, EJ; Kim, S; Kuhar, MJ; Scheffel, U | 1 |
| Coutaux, AF; Mooney, JJ; Wirth, DF | 1 |
| Jackson, CW; Lydiard, RB; Morton, WA | 1 |
| Iacono, RP; Toyama, SC | 1 |
| Alderman, J; Chung, M; Harris, S; Harrison, W; Messig, M; Preskorn, SH | 1 |
| Calabrese, JR; Rapport, DJ | 1 |
| Aguglia, E; Bolino, F; Casacchia, M; Cassano, GB; Faravelli, C; Ferrari, G; Giordano, P; Pancheri, P; Ravizza, L; Trabucchi, M | 1 |
| Ellison, JM; Stanziani, P | 1 |
| Hollander, E; Josephson, SC; Stein, DJ | 1 |
| Bandettini, F; Bhatara, VS | 1 |
| Lauder, JM; Sadler, TW; Shuey, DL; Tamir, H; Yavarone, MS | 1 |
| Kleven, MS; Woolverton, WL | 1 |
| Kupfer, DJ | 1 |
| Binkley, SN; Ring, BJ; Roskos, L; Wrighton, SA | 1 |
| LaBranche, S | 1 |
| Hsu, JH; Shen, WW | 1 |
| McConnell, JG; Taylor, IC | 1 |
| Burke, MJ; Harvey, AT; Preskorn, SH | 1 |
| Cole, JO; Kando, JC; Tohen, M; Weiss, MK; Zarate, CA | 1 |
| Duman, RS; Nestler, EJ; Nibuya, M | 1 |
| Joffe, RT; Levitt, AJ; Sokolov, ST; Young, LT | 1 |
| Bhatara, VS; Freeman, JW; Gupta, S | 1 |
| Berman, R; Charney, DS; Delgado, PL; Heninger, GR; Krystal, JH; Miller, HL; Salomon, RM | 1 |
| Baldessarini, RJ; Centorrino, F; Flood, JG; Frankenburg, FR; Kando, J; Volpicelli, SA | 1 |
| Newhouse, PA | 1 |
| Balon, R | 1 |
| Koran, LM; Maloney, A; Mueller, K | 1 |
| Knowles, SR; Liu, BA; Mittmann, N; Shear, NH | 1 |
| Darmani, NA | 2 |
| Reynolds, CF | 1 |
| Carpenter, LL; Epperson, CN; McDougle, CJ; Price, LH | 1 |
| Harvey, AT; Preskorn, SH | 1 |
| Leo, RJ | 1 |
| Harnett-Sheehan, K; Sheehan, DV | 1 |
| de Vet, HC; Hartmans, M; Honig, A; Menting, JE; Rozendaal, N; van Praag, HM; Verhey, FR | 1 |
| Kurz, X; Ottervanger, JP; Roisin, T; Stricker, BH; Van Ermen, AM | 1 |
| Bélanger, PM; Hamelin, BA; LeBel, M; Paquet, F; Turgeon, J; Vallée, F | 1 |
| Darmani, NA; Reeves, SL | 1 |
| Baumann, P; Eap, CB | 1 |
| MacKay, AV; Price, JS; Waller, PC; Wood, SM | 1 |
| Bradford, JM; Curry, S; Greenberg, DM; O'Rourke, A | 1 |
| Labbate, LA; Oleshansky, MA | 1 |
| Berti, C; Burnett, F; Cooney, J; Dash, A; Dinan, TG; Lavelle, E; Scott, L; Thakore, J | 1 |
| Apter, JT; Birkett, MA; Blomgren, SL; Tepner, RG; Thase, ME | 1 |
| Daniel, WA; Wójcikowski, J | 3 |
| Rifkin, A | 1 |
| Meier, E; Sánchez, C | 1 |
| Charness, WE; Ferrando, SJ; Goldman, JD | 1 |
| Earley, B; Faherty, CJ; Leonard, BE | 1 |
| Devine, CL; Markowitz, JS | 1 |
| DePalma, RL; Katholi, CR; Modell, JD; Modell, JG | 1 |
| Mellerup, ET; Plenge, P | 1 |
| Agosti, V; Stewart, JW | 1 |
| Baldessarini, RJ; Bodkin, JA; Gardner, DM; Lasser, RA; Wines, JD | 1 |
| Byrne, S; Rothschild, AJ | 1 |
| Darby, AL; Lesser, IM; Miller, BL; Swartz, JR | 1 |
| Constantino, JN; Kincaid, M; Liberman, M | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Findling, RL | 1 |
| Brenner, EM; King, RA; Lynch, KA; Scahill, L; Vitulano, LA | 1 |
| Mitchell, S; Tracy, KA; Zajecka, J | 1 |
| Jaffe, IA; Rudikoff, D | 1 |
| Anand, A; Barr, LC; Goodman, WK; McDougle, CJ; Price, LH | 1 |
| Bousoño, M; Calcedo, A; Carrasco, JL; Ciudad, J; Daniel, E; De la Gandara, J; Derecho, J; Franco, M; Gomez, MJ; Izquierdo, JA; Ledesma, A; Llorca, G; Macias, JA; Martin, T; Montejo-González, AL; Perez, V; Sanchez, JM; Sanchez, S; Vicens, E | 1 |
| Richelson, E | 1 |
| Gregor, KJ; James, SP; Way, K; Young, CH | 1 |
| Bisserbe, JC; Flament, MF | 1 |
| Gorman, JM | 1 |
| Cohen, LS | 1 |
| Cohen, CI; Trappler, B | 1 |
| Edwards, IR; Fletcher, AP; Lindquist, M; Pettersson, M; Sanderson, JH; Schou, JS; Stahl, MM; Taylor, NF | 1 |
| Buesching, DP; Croghan, TW; Crown, WH; Heiligenstein, JH; Hylan, TR; Melfi, CA; Meneades, L | 2 |
| Fawcett, J; Mitchell, S; Zajecka, J | 1 |
| Purdon, SE; Snaterse, M | 1 |
| Grimes, JB; Hines, A; Labbate, LA; Pollack, MH | 1 |
| Evanoff, A; Newton, WP | 1 |
| Mazo, GE; Razorenov, GI; Razorenova, TS; Vovin, RIa | 1 |
| Andrews, W; Barrett, E; Parker, G | 1 |
| Arana, GW; Grimes, JB; Labbate, LA | 1 |
| Ruiz, P; Small, DR; Varner, RV | 1 |
| Goldstein, DJ | 1 |
| Ascroft, RC; Fava, M; Hoog, SL; Krebs, WB; Rosenbaum, JF | 1 |
| Kim, SC; Seo, KK | 1 |
| Belpaire, FM; Brøsen, K; Rasmussen, BB; Temmerman, A; Wijnant, P | 1 |
| Hengeveld, MW; Olivier, B; Waldinger, MD; Zwinderman, AH | 1 |
| Borrell, L; Foreyt, JP; Haddock, CK; Poston, WS | 1 |
| Bourin, M; Redrobe, JP | 1 |
| Roose, SP; Suthers, KM | 1 |
| Barbey, JT; Roose, SP | 1 |
| Arlinghaus, KA; Clearman, RR; George, MS; Kotrla, KJ; Nahas, Z | 1 |
| Thompson, C | 1 |
| Bourgeois, JA; Johansen, T; Thomas, D; Walker, DM | 1 |
| Stahl, SM | 1 |
| Voris, JC | 1 |
| Bisserbe, JC; Boyer, P; Danion, JM; Hotton, JM; Troy, S | 1 |
| Altshuler, L; Cantrell, R; Gillespie, W | 1 |
| Alfaro, CL; Ereshefsky, L; Lam, YW; Simpson, J | 2 |
| Meyers, BS | 1 |
| Baker, GB; Fletcher, PJ; Greenshaw, AJ; Sills, TL | 1 |
| Batzar, E; Clary, CM; Finkel, SI; Richter, EM | 1 |
| Daniel, WA; Haduch, A; Syrek, M; Wójcikowski, J | 2 |
| Erenmemisoglu, A; Ozdogan, UK; Saraymen, R; Tutus, A | 1 |
| Carleborg, L; Hägg, S; Ohman, R; Spigset, O | 1 |
| Sheehan, DV | 1 |
| Hensley, PL; Nurnberg, HG; Paine, SS; Thompson, PM | 1 |
| Galin, RS; Robison, LM; Sclar, DA; Skaer, TL | 1 |
| Hensley, PL; Nurnberg, HG; Thompson, PM | 1 |
| Flament, MF; Lane, RM; Ying, Z; Zhu, R | 1 |
| Berndt, ER; Colucci, S; Grudzinski, AN; Miceli, R; Russell, JM | 1 |
| Boyer, P; Paternetti, S; Sechter, D; Troy, S | 1 |
| de Moore, GM; Ferrando, SJ; Rabkin, JG; Rabkin, R | 1 |
| Seiden, LS; Sokolowski, JD | 1 |
| Atan, A; Aydogănli, L; Baykam, M; Murat Başar, M; Yildiz, M | 1 |
| McMahon, CG; Samali, R | 1 |
| Amsterdam, J; Apter, J; Fava, M; Londborg, P; Michelson, D; Pagh, L; Tamura, R | 1 |
| Härtter, S; Hiemke, C | 1 |
| Feinstein, A; McCullagh, S | 1 |
| Kalia, M; Kramer, M; Miller, DB; O'Callaghan, JP | 1 |
| Bebawy, LI; El-Kousy, N; Shokry, M; Suddik, JK | 1 |
| Ballester, R; Chuan, P; Domenech, C; Lluch, S; Medina, P; Segarra, G; Vila, JM | 1 |
| Anisman, H; Griffiths, J; Merali, Z; Ravindran, AV; Zaharia, MD | 1 |
| Sansone, RA; Shrader, JA; Wiederman, MW | 1 |
| Garcìa-Rodrìguez, JA; Munoz-Bellido, JL; Munoz-Criado, S | 1 |
| Borgeat, F; Freeston, MH; Todorov, C | 1 |
| Han, JH; Kim, SC; Lee, MY; Seo, KK | 1 |
| Hostetter, A; Llewellyn, A; McLaughlin, E; Stowe, ZN; Strader, JR | 1 |
| Dunn, NR; Freemantle, SN; Mackay, FR; Mann, RD; Martin, RM; Pearce, GL | 1 |
| Fava, M; Hoog, SL; Kopp, JB; Nilsson, ME; Rosenbaum, JF; Tepner, RG | 1 |
| Gentilini, G; Lopez-Silva, S; Lucca, A; Soldarini, A | 1 |
| Anthony, JP; Neumaier, JF; Sexton, TJ | 1 |
| Jurima-Romet, M; Neigh, S; Wright, M | 1 |
| Baier, D; Kohnen, R; Philipp, M; Tiller, JW | 1 |
| Batzar, ED; Clary, CM; Doraiswamy, PM; Krishnan, KR; Newhouse, PA; Richter, EM | 1 |
| Court, MH; Duan, SX; Greenblatt, DJ; Hesse, LM; Shader, RI; Venkatakrishnan, K; von Moltke, LL | 1 |
| Buzinkaiová, T; Polonský, J | 1 |
| Arik, AC; Celik, S; Kurt, M | 1 |
| Pearlstein, T; Steiner, M | 1 |
| Deslandes, PN; Pache, DM; Sewell, RD; Subhan, F | 1 |
| Woods, SW | 1 |
| Fava, M; Hoog, SL; Judge, R; Koke, SC; Nilsson, ME | 1 |
| Fitzgerald, F; Glod, CA; Lynch, A | 1 |
| Altshuler, LL; Calcagno, JL; Frye, MA; Gitlin, MJ; Hwang, S; Rasgon, NL; Suri, RA; Zuckerbrow-Miller, J | 1 |
| Ferguson, JM | 1 |
| Bayer, BM; Pellegrino, TC | 1 |
| Birnbaum, AK; Nelson, MH; Remmel, RP | 1 |
| Altman, CA | 1 |
| Dewa, CS; Goering, P; Hoch, JS | 1 |
| Clary, CM; Doraiswamy, PM; Krishnan, KR | 1 |
| Cook, IA; Leuchter, AF | 1 |
| Panzarino, PJ; Xuan, J | 1 |
| Kim, SC; Lee, MY; Seo, KK | 1 |
| Bergsholm, YK; Bøhler, E; Nordeng, H; Spigset, O | 1 |
| Daniel, WA; Pałucha, A; Wójcikowski, J | 1 |
| Clary, CM; Colucci, SV; Grudzinski, AN; Miceli, RJ; Roy-Byrne, PP; Xu, Y | 1 |
| Lin, J; Thompson, DS | 1 |
| Carr, M | 1 |
| Dolor, R; Eckert, GJ; Gilsenan, A; Hays, R; Kroenke, K; Stang, P; Swindle, R; Weinberger, M; West, SL; Zhou, XH | 1 |
| Fornal, CA; Jacobs, BL; Metzler, CW; Mirescu, C; Stein, SK | 1 |
| Kane, JM | 1 |
| Anheuer, ZE; Bagdy, G; Graf, M; Kantor, S; Modos, EA | 1 |
| Bauer, MS; Glick, HA; Onesirosan, P; Polsky, D | 1 |
| Connor, KM; Davidson, JR; Tharwani, HM | 1 |
| Hwang, O; Kim, SW; Park, SY | 1 |
| Fava, M; Gonzales, JS; Hoog, SL; Judge, RA; Kopp, JB; Nilsson, ME | 1 |
| Austin, C; Bergeron, R; Chaput, Y; Goldner, E; Hadrava, V; Ravindran, AV; Swinson, R; van Ameringen, MA | 1 |
| Boulton, DW; DeVane, CL; Goldman, J; Liston, HL; Markowitz, JS; Risch, SC | 1 |
| Brown, EB; Gonzales, JS; Miner, CM; Munir, R | 1 |
| Dane, FC; Elliott, RL | 1 |
| Stopa, SF | 1 |
| Culpepper, L; Heeren, T | 1 |
| Keeley, R | 1 |
| Raphael, K; Tokeshi, J | 1 |
| Cronholm, P; Straton, JB | 1 |
| Morsch, VM; Müller, TC; Neis, RT; Rocha, JB; Schetinger, MR | 1 |
| Gupta, S | 1 |
| Cullen, N; Lexell, J; Zafonte, RD | 1 |
| Alfaro, CL; Ereshefsky, L; Gaedigk, A; Lam, YW; Simpson, J | 1 |
| Kline, NA; Matloff, JL; Stein, MB | 1 |
| De La Fuente, JA; De Las Cuevas, C; Sanz, EJ | 1 |
| Swiecicki, Ł; Szafrański, T | 1 |
| Anderson, TA; Dobscha, SK; Hauser, P; Hoffman, WF; Snodgrass, LS; Turner, EH; Winterbottom, LM | 1 |
| Banti, S; Borri, C; Camilleri, V; Cassano, GB; Mauri, M; Miniati, M; Pini, S; Rotondo, A | 1 |
| Lo Sasso, AT; Sheffield, RE; Way, K; Young, CH | 1 |
| Caltagirone, C; Guida, G; Spalletta, G | 1 |
| Levenson, JL | 1 |
| Altshuler, LL; Haynes, D; Hendrick, V; Hwang, S; Lee, E; Stowe, ZN | 1 |
| Czarnecka, E; Pietrzak, B | 1 |
| Abdel-Salam, OM; El-Shenawy, SM; Nofal, SM | 1 |
| Boyer, P; Feiger, AD; Flament, MF; Gillespie, JA | 1 |
| Varley, CK | 1 |
| Broocks, A; Hohagen, F; Kordon, A | 1 |
| Akin, A; Chaturvedi, AK | 1 |
| Burt, T; Clary, CM; Coffey, DJ; Doraiswamy, PM; Jenkyn, LR; Krishnan, KR; Oxman, T | 1 |
| Cheng, KT; DeVane, CL; Donovan, JL; Liston, HL; Markowitz, JS; Risch, SC; Willard, L | 1 |
| Baker, GB; Fletcher, PJ; Salsali, M; Sinyard, J | 1 |
| Kim, SW; Lee, SH; Paick, JS | 1 |
| Anand, A; Berman, RM; Charney, DS; Lynch-Colonese, K; Perry, EB; Sanacora, G | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Carella, A; Cheok, A; Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Potter, WZ; Sagrati, S; Spencer, EP; Wilson, AA | 1 |
| Cryan, JF; Dalvi, A; Friedland, JC; Hirsch, BR; Jin, SH; Lucki, I; O'Leary, OF; Ouyang, M; Page, ME; Thomas, SA | 1 |
| Abdel Salam, OM | 1 |
| Brown, EB; Joliat, MJ; Miner, CM | 1 |
| Eckert, G; Greco, T; Kroenke, K | 1 |
| Eichner, SF; Jones, JR; Moore, ML | 1 |
| Kumar, SN; Ramanathan, M; Suresh, B | 1 |
| Armbrust, KL; Black, MC; Henry, TB; Kwon, JW | 1 |
| Hirano, K; Kagawa, Y; Kimura, R; Maruyama, S; Yamada, S | 1 |
| Albert, U; Bogetto, F; Maina, G; Salvi, V | 1 |
| Cederberg, J; Knight, S; Melhus, H; Svenson, S | 1 |
| Connor, KM; Davidson, JR; Foa, EB; Hertzberg, MA; Payne, VM; Rothbaum, BO; Weisler, RH | 1 |
| Hashimoto, H; Hirano, K; Kato, Y; Kimura, R; Sugimoto, Y; Uchida, S; Yamada, J; Yamada, S | 1 |
| Banks, KE; Brooks, BW; Chambliss, CK; Johnson, RD; Lewis, RJ; Ramirez, A; Stanley, JK | 1 |
| Cela, R; Garcia-Jares, C; Lamas, JP; Llompart, M; Salgado-Petinal, C | 1 |
| Bestari, KJ; Brain, RA; Johnson, DJ; Sanderson, H; Solomon, KR; Wilson, CJ | 1 |
| Briley, KA; Goodale, ES; Gopal, KV; Hendea, OM | 1 |
| Bonikovski, V; Futuro-Neto, HA; Pires, JG | 1 |
| Lambert, WE; Maudens, KE; Van Peteghem, CH; Wille, SM | 1 |
| Carrasco, JL; Sandner, C | 1 |
| Gupta, G; Kumar, VS; Maikhuri, JP; Sharma, VL; Singh, D; Singh, MM; Tiwari, P | 1 |
| Bria, P; Caltagirone, C; Ripa, A; Robinson, RG; Spalletta, G | 1 |
| Lavori, PW; Roose, SP; Sackeim, HA | 1 |
| Berger, U; Jensen, E; Kallenborn, R; Samuelsen, PJ; Vasskog, T | 1 |
| de Abajo, FJ; Madurga, M; Montero, D; Rodríguez, LA | 1 |
| Csoka, AB; Shipko, S | 1 |
| Higuchi, T; Honda, K; Kamijima, K; Kitahara, S; Tanaka, S; Yamada, M | 1 |
| Dinan, TG; O'Brien, SM; Scott, LV | 1 |
| Brain, RA; Johnson, DJ; Sanderson, H; Solomon, KR; Wilson, CJ | 1 |
| Greenhill, LL; Moreno, C; Roche, AM | 1 |
| Carroll, BJ; Chang, YH; Kim, DK; Kim, H; Kim, JW; Kim, S; Lim, SW | 1 |
| Bailly, D | 1 |
| Eastwood, BJ; Jones, CK; Need, AB; Shannon, HE | 1 |
| Haro, JM; Peñarrubia, MT; Pinto-Meza, A; Serrano-Blanco, A; Suárez, D | 1 |
| Bremner, JD; Charney, DS; Vermetten, E; Vythilingam, M | 1 |
| Choi, J; Golbeck, AL; Neff, M; Preskorn, SH; Shah, R | 1 |
| Kuczynski, E; Thomé-Souza, MS; Valente, KD | 1 |
| Nogueira, RL; Zangrossi, H; Zanoveli, JM | 1 |
| Coffey, B; Kotcher, L; Wieland, N | 1 |
| Dean, AJ; Hendy, A; McGuire, T | 1 |
| Fountoulakis, KN; Iacovides, A; Samolis, S; St Kaprinis, G | 1 |
| Connor, K; Davidson, JR; Vaishnavi, S | 1 |
| Alacqua, M; Arcoraci, V; Calarese, T; Di Vita, G; Gagliano, C; Germanò, E; Magazù, A; Spina, E; Trifirò, G | 1 |
| Hetrick, S; McKenzie, J; Merry, S; Proctor, M; Sindahl, P | 1 |
| Hernández-Pérez, R; La Rotta-Higuera, E; Piquero-Casals, J; Piquero-Casals, V; Piquero-Martín, J | 1 |
| Bekele, NB; Shih, YC; Xu, Y | 1 |
| Benattia, I; Demitrack, M; Entsuah, R; Nemeroff, CB; Sloan, DM; Thase, ME | 1 |
| Fineberg, NA; Ipser, J; Pallanti, S; Pampaloni, I; Stein, DJ | 1 |
| Han, C; Jung, IK; Ko, YH; Lee, BH; Masand, PS; Pae, CU; Patkar, AA | 1 |
| Busto, G; Di Spigno, D; Falcini, R; Salvati, L; Tundo, A | 1 |
| Hanson, ML; Kelly, SE; Richards, SM | 1 |
| Ghanizadeh, A | 1 |
| Barton, R | 1 |
| Olivier, B; Schweitzer, DH; Waldinger, MD; Zwinderman, AH | 1 |
| Al-Zaman, Y; Aylwin, S | 1 |
| Holman, JR; Kimmer, SL; Lo, V; Mercado, MG; Wanserski, G | 1 |
| Berman, RM; Carson, WH; Fava, M; Hennicken, D; Marcus, RN; McQuade, RD; Simon, JS; Thase, ME; Trivedi, MH | 1 |
| Ermani, M; Freo, U; Merico, A; Ori, C | 1 |
| Aperi, J; Borenstein, J; Jones, JB; Karne, A; Shah, NR; Shemtov, R | 1 |
| Bévalot, F; Fanton, L; Gaillard, Y; Grait, H; Le Meur, C; Malicier, D | 1 |
| Brustolin, A; Campisi, S; Fassino, S; Lavagnino, L; Leombruni, P; Pierò, A | 1 |
| Buitelaar, JK; Roobol, TH | 1 |
| Balch, AH; Berman, RM; Boulton, DW; Mallikaarjun, S; Patel, CG; Reeves, RA; Royzman, K | 1 |
| Manassis, K; Tannock, R | 1 |
| Ikonomidis, I; Kremastinos, DT; Lekakis, J; Moutsatsou, P; Nikolaou, M; Papoutsi, Z; Parissis, J | 1 |
| Vitiello, B | 1 |
| Patel, BN; Sanyal, M; Sharma, N; Shrivastav, PS | 1 |
| Karpowich, NK; Law, CJ; Reith, ME; Wang, DN; Zhen, J; Zhou, Z | 1 |
| Ahrold, TK; Meston, CM | 1 |
| Carrilho, E; Catai, AP; Lanças, FM; Queiroz, ME | 1 |
| Armbrust, KL; Black, MC; Conners, DE; Kwon, JW; Rogers, ED | 1 |
| Bahls, SC; Boeving, A; de Carvalho, GA; Graf, H | 1 |
| Lanza di Scalea, T; Wisner, KL | 1 |
| Kadioglu, M; Kalyoncu, NI; Kesim, M; Muci, E; Ozyavuz, R; Yaris, E | 1 |
| DeVeaugh-Geiss, AM; Gaynes, BN; Kroenke, K; Miller, WC; Sleath, B; West, SL | 1 |
| Baumer, C; Koren, G; O'Brien, L; Sachs, H; Thieme, D | 1 |
| Drummer, OH; Gerostamoulos, D; Pilgrim, JL | 1 |
| Gricar, J; Rendas-Baum, R; Wallenstein, GV; Yang, M | 1 |
| Charles, D; Fava, M; Papakostas, GI | 1 |
| Dormuth, CR; Lee, JC; Mehta, J; Miller, M; Patrick, AR; Schneeweiss, S; Solomon, DH; Wang, PS | 1 |
| Gilbert, AR; Maalouf, FT | 1 |
| Kenchaiah, BK; Kumar, S; Tharyan, P | 1 |
| Nierenberg, AA; Schutte, AJ; Simmons, JH; Thase, ME; van Oers, HJ; Vrijland, P | 1 |
| Barbosa, V; Ghaziuddin, M; Ghaziuddin, N; Gih, D; Maixner, DF | 1 |
| Agius, M; Gardner, J; Liu, K; Zaman, R | 1 |
| Mochcovitch, MD; Nardi, AE | 1 |
| Antonioli, L; Blandizzi, C; Colucci, R; Corona, T; Fornai, M; Mantarro, S; Montagnani, S; Pergola, A; Ruggiero, E; Scollo, C; Testi, A; Tuccori, M | 1 |
| Garber, JR; McCowen, KC | 1 |
| Halling-Sørensen, B; Ingerslev, F; Styrishave, B | 1 |
| Dobzhenko, MN; Shchepotin, IB; Zotov, AS | 1 |
| Ameral, VE; Bitran, S; Clain, AJ; Farabaugh, AH; Fava, M; LaRocca, RA; Mischoulon, D | 1 |
| Kardeh, E; Mowla, A | 1 |
| Bartell, SE; Furlong, ET; Logue, A; Painter, MM; Schoenfuss, HL; Schultz, MM; Werner, SL | 1 |
| Beste, J; Blackwell, JC; Patel, BN | 1 |
| Bisson, JI | 1 |
| Alvarado, G; Artigas, F; Bortolozzi, A; Carmona, MC; Castañé, A; Cortés, R; Fernández, G; Ferrés-Coy, A; Montefeltro, A; Perales, JC; Santana, N; Semakova, J; Toth, M | 1 |
| Abman, SH; Delaney, C; Gien, J; Grover, TR; Roe, G | 1 |
| Dasgupta, K; Labos, C; Nedjar, H; Rahme, E; Turecki, G | 1 |
| Chamielec, M; Gałecki, P; Talarowska, M; Zboralski, K | 1 |
| Cavanna, AE; Rickards, H; Worrall, R | 1 |
| Maraschin, M; Rodrigues, AL; Tasca, CI; Zeni, AL; Zomkowski, AD | 1 |
| Dahmen, N; Engel, A; Gerbaulet, M; Hiemke, C | 1 |
| Mandrioli, R; Mercolini, L; Raggi, MA; Saracino, MA | 1 |
| Gouffon, JS; Heah, TP; Henry, TB; Park, JW; Sayler, GS | 1 |
| Cortés, JM; Hidalgo, M; Jönsson, JÅ; Larsson, E; Sagristà, E; Salvadó, V | 1 |
| Carroll, BJ; Chung, JW; Kim, DK; Kim, H; Kim, JW; Kim, S; Lim, SW; Myung, W; Seo, MY | 1 |
| Cox, GR; Hetrick, SE; McKenzie, JE; Merry, SN; Simmons, MB | 1 |
| Claxton, A; Hackett, ML; Hankey, GJ; Hsieh, CF; Kutlubaev, MA; Lee, R; Mead, GE | 1 |
| Kováru, F; Kovárů, H; Lisá, V | 1 |
| D'iakonov, AL; Lobanova, IV | 1 |
| Boura-Halfon, S; Gurevitch, D; Isaac, R; Levkovitz, Y; Shainskaya, A; Zick, Y | 1 |
| Gibb, W; Ho, HL; Iqbal, M; Kapoor, A; Matthews, SG; Petropoulos, S | 1 |
| Corruble, E; Demyttenaere, K; Hale, A; Kasper, S; Picarel-Blanchot, F; Quera-Salva, MA | 1 |
| Gorman, DA; Lam, D; Patten, S; Pringsheim, T | 1 |
| Abdel Salam, OM; Farrag, AR; Mohammed, NA; Sleem, AA | 1 |
| Eibak, LE; Gjelstad, A; Parmer, MP; Pedersen-Bjergaard, S; Rasmussen, KE | 1 |
| Cekmen, M; Dursun, M; Kirecci, SL; Otunctemur, A; Ozbek, E; Ozcan, L; Ozdogan, HK | 1 |
| Cho, HY; Kim, JE; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Seo, MK; Seol, W | 1 |
| Bossus, MC; Ford, AT; Guler, YZ; Morrison, ER; Short, SJ | 1 |
| Degirmencioglu, S; Gurbuz, ZG; Kirecci, SL; Mimaroglu, S; Simsek, A; Vural, P; Yuksel, A | 2 |
| Sato, Y | 1 |
| Amano, T | 1 |
| Handley, AP; Williams, M | 1 |
| Futuro Neto, HA; Pires, JG; Ramage, AG; Santuzzi, CH; Silva, NF; Tiradentes, RV | 1 |
| Becker, T; Koesters, M; Ma, Y; Zhang, Y | 1 |
| Howard, LM; Karia, AM; McGeown, HR; Molyneaux, E; Trevillion, K | 1 |
| Alparslan, S; Eryilmaz, G; Isiten, N; Mutlu, C; Ozilhan, S; Saglam, E; Yorbik, O | 1 |
| Hassanpour Moghadam, M; Mohajeri, SA; Sajadi Tabassi, SA; Talaei, A | 1 |
| IsHak, WW; Karamians, R; Peselow, ED; Pizano, D; Tobia, G | 1 |
| Hermann, M; Molden, E; Waade, RB | 1 |
| Dueñas, H; Haro, JM; Hong, J; Moneta, MV; Montgomery, W; Novick, D; Peng, X | 1 |
| Barbui, C; Cipriani, A; Furukawa, TA; Hayasaka, Y; Leucht, S; Magni, LR; Ogawa, Y; Purgato, M; Takeshima, N | 1 |
| Banzi, R; Cusi, C; Moja, L; Randazzo, C; Sterzi, R; Tedesco, D | 1 |
| Alvarado, G; Artigas, F; Bortolozzi, A; Campa, L; Caso, JR; Ferrés-Coy, A; Galofré, M; Leza, JC; Montefeltro, A; Paz, V; Pazos, Á; Pilar-Cuéllar, F; Ruiz-Bronchal, E; Valdizán, EM; Vidal, R | 1 |
| Halling-Sørensen, B; Hansen, CH; Jacobsen, NW; Nellemann, C; Styrishave, B | 1 |
| Avramescu, ET; Dănciulescu Miulescu, R; Ilie, M; Manda, G; Margină, DM; Neamţu, MC; Purdel, NC | 1 |
| Bloch, MH; Freemantle, N; Jakubovski, E; Taylor, MJ; Varigonda, AL | 1 |
| Azrael, D; Bushnell, GA; Miller, M; Pate, V; Stürmer, T; Swanson, SA; White, A | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Craig, JC; Natale, P; Palmer, SC; Rabindranath, KS; Ruospo, M; Saglimbene, VM; Strippoli, GF | 1 |
| Andreão, RV; Benseñor, IM; Bittencourt, MS; Brunoni, AR; Dantas, EM; Fráguas, R; Kemp, AH; Koenig, J; Lotufo, PA; Mill, JG; Nunes, MA; Ribeiro, AL; Thayer, JF | 1 |
| Asadpour, R; Bahramali, E; Erfani, N; Firouzabadi, N; Shayesteh, MR; Shoushtari, AA; Yavarian, I | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Arkar, H; Bildik, T; Sevi Tok, ES | 1 |
| Brown, N; Cotton, RB; Delaney, C; Hooper, CW; Poole, S; Reese, J; Shelton, EL; Slaughter, JC; Streeter, T; Yarboro, MT | 1 |
| DeLucia, V; Kelsberg, G; Safranek, S | 1 |
| Berglund, O; Boström, ML; Jönsson, JÅ; Ugge, G | 1 |
| Adamczak, SK; Bury, TBS; Donovan, EE; Fong, PP; Lambert, OJ; Palmucci, JR | 1 |
| Melvin, SD | 1 |
| Brose, SA; Golovko, MY; Henry, LK; Krout, D; Rodriquez, M; Thompson, BJ | 1 |
| Bertozzi, CR; Fox, DM; Riley, LW; Schump, MD | 1 |
| Çetin, B; Ergelen, M | 1 |
| Aggour, AM; Al-Ghafari, A; Almutairi, FM; Carter, WG; Elmorsy, E | 1 |
| Bartova, L; Dold, M; Kasper, S; Rupprecht, R | 1 |
| He, JC; Pu, ZP; Xia, JM; Xie, W | 1 |
| Bureau, R; Halm-Lemeille, MP; Minguez, L | 1 |
| Donders, GGG; Martinez-de-Oliveira, J; Oliveira, AS; Palmeira-de-Oliveira, A; Palmeira-de-Oliveira, R | 1 |
| Dolezelova, P; Faggio, C; Sehonova, P; Svobodova, Z; Vosmerova, P | 1 |
| Bogdanova, OV; D'Anci, KE; Kanekar, S; Olson, PR; Ombach, HJ; Petersen, M; Renshaw, CE; Renshaw, PF; Sheth, CS; Sung, YH | 1 |
| Carleton, BC; Etminan, M; Guo, MY; Kezouh, A; Kim, DD; Procyshyn, RM; Samii, A | 1 |
| Gao, YL; He, B | 1 |
| Gui, J; Maguen, S; Schnurr, PP; Shiner, B; Watts, BV; Westgate, CL; Young-Xu, Y | 1 |
| Clabault, H; Cohen, M; Sanderson, JT; Vaillancourt, C | 1 |
| Aitchison, KJ; Binder, EB; Carrillo-Roa, T; Cattaneo, A; DeModena, A; Henigsberg, N; Kelsoe, JR; Leckband, SG; Liu, JJ; McCarthy, M; Mors, O; Ren, H; Rietschel, M; Shekhtman, T; Wei, YB | 1 |
| Assimon, MM; Brookhart, MA; Flythe, JE | 1 |
| Barbacci, DC; Bonci, A; Jackson, SN; Woods, AS | 1 |
| Feng, S; Gu, J; Jiang, X; Tang, S; Wang, L; Zheng, L | 1 |
| Arnold, PD; Bousman, C; Greenslade, A; Maruf, AA | 1 |
| Chen, L; Cheng, S; Guo, S; Xu, H | 1 |
| Bacon, F; Clarke, CS; Donkor, Y; Duffy, L; Freemantle, N; Gilbody, S; Hunter, R; Kendrick, T; Kessler, D; King, M; Lanham, P; Lewis, G; Mangin, D; Marston, L; Moore, M; Nazareth, I; Wiles, N | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Nilsson, S | 1 |
| Arumugasaamy, N; Fisher, JP; Gudelsky, A; Hurley-Novatny, A; Kim, PCW | 1 |
| Bolding, IJ; Boone, DR; Cardenas, C; DeWitt, DS; Falduto, MT; Hellmich, HL; Micci, MA; Prough, DS; Sell, SL; Torres, KEO; Weisz, HA; Willey, HE | 1 |
| Barata, C; Gómez-Canela, C; Marcé, RM; Martínez-Jerónimo, F; Rovira García, X | 1 |
| Alsaab, S; Cobb, C; Haidari, M; Mansani, S; Ponds, D; Romero, L | 1 |
| Doucet, N; Hudon Thibeault, AA; López de Los Santos, Y; Sanderson, JT; Vaillancourt, C | 1 |
| Arumugasaamy, N; Fisher, JP; Hurley-Novatny, A; Kim, PCW; Lembong, J | 1 |
| Bezerra, MS; Gavioli, EC; Gomes, LTDC; Martins, ABM; Pontes, THA; Silva Junior, EDD; Trajano, FMG | 1 |
| Ahemad, N; Dong, AN; Ong, CE; Palanisamy, UD; Pan, Y; Yiap, BC | 1 |
| Byeon, E; Hagiwara, A; Han, J; Lee, JS; Park, JC | 1 |
| Liao, XM; Si, TM; Su, YA; Wang, Y; Yu, X | 1 |
| Frecska, E; Mathe, E; More, C; Szoke-Kovacs, R; Szoke-Kovacs, Z | 1 |
| Baker, A; Bisson, JI; Dekker, W; Hoskins, MD | 1 |
| Bagaturiya, G; Lenskaya, K; Petrosyan, M; Proshin, S; Samedov, А | 1 |
| Cornelius, SL; Gui, J; Hoyt, JE; Leonard, CE; Schnurr, PP; Shiner, B; Watts, BV; Young-Xu, Y | 1 |
| Flannagan, KS; Kim, K; Mumford, SL; Perkins, NJ; Radoc, JG; Schisterman, EF; Silver, RM; Sjaarda, LA | 1 |
| Hui, A | 1 |
| Eriksson, E; Hieronymus, F; Lisinski, A; Wallerstedt, SM | 1 |
| Hamill Skoch, S; Mills, JA; Ramsey, L; Strawn, JR | 1 |
| Badcock, PB; Bailey, AP; Cox, GR; Hetrick, SE; McKenzie, JE; Meader, N; Merry, SN; Moller, CI; Sharma, V | 1 |
| Haas, DM; Marks, C; Quinney, SK; Silvola, R; Teal, E | 1 |
| Khan, JA; Nadeem, MS; Rashid, U | 1 |
| Hayes, P; Kelly, D; Lukas, K; McCool, A | 1 |
| Aghaeepour, N; Maric, I; Oskotsky, B; Oskotsky, T; Sirota, M; Stevenson, DK; Tang, A; Wong, RJ | 1 |
| Komarov, SD; Severtsev, VV; Vdovin, AS; Vinnikova, MA | 1 |
| Bell, AM; Charles, JF; Domingues, RR; Hernandez, LL; Hunt, ER; Manuel, RSJ; Sartori, LC; Scharpf, BR; Sheftel, CM; Vezina, CM; Wake, LA | 1 |
| Camino, S; Godoy, A; Smith, J; Strejilevich, SA; Szmulewicz, A | 1 |
| Eryilmaz, M; Gurpinar, SS; Kart, D | 1 |
| Bracke, F; Frieling, H; Leffler, A | 1 |
| Dai, Y; Gao, H; Huang, Y; Jiang, H; Liu, Q; Wang, M; Zhang, X | 1 |
| Kenda, M; Sollner Dolenc, M; Zore, T | 1 |
| Al-Khatib, SM; Assimon, MM; Brookhart, MA; Flythe, JE; Gaynes, BN; Pun, PH; Winkelmayer, WC | 1 |
| Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S | 1 |
| Azoulay, L; Cao, TXD; Fergusson, E; Filliter, C; Montastruc, F; Rej, S; Renoux, C; Yu, OHY | 1 |
| Baweja, R; Gomaa, H; Joshi, A | 1 |
| Hatano, M; Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Okuya, M; Sakuma, K | 1 |
| Duarte, D; Nunes, M; Ricardo, S; Vale, N | 1 |
| Mimura, M; Sakurai, H; Suzuki, T; Takeuchi, H; Tsujii, T; Uchida, H | 1 |
| Estruch, IM; van den Brink, NW; van der Most, MA | 1 |
| Amada, N; Futamura, T; Hirose, T; Kakumoto, Y; Kikuchi, T; Maeda, K; Suzuki, M | 1 |
| Alexandre, C; Alexandre, J; Desaunay, P; Dreyfus, M; Eude, LG; Fedrizzi, S; Guénolé, F; Uguz, F | 1 |
| Kelley, L; Laschober, R; Sartor, Z | 1 |
| Asadi-Pooya, AA; Firouzabadi, N; Kashkooli, M; Malekpour, M; Zamiri, B | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
88 review(s) available for fluoxetine and sertraline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Small Molecules Selectively Targeting Sigma-1 Receptor for the Treatment of Neurological Diseases.
Topics: Allosteric Regulation; Clinical Trials as Topic; Humans; Ligands; Nervous System Diseases; Piperidines; Receptors, sigma; Sigma-1 Receptor; Small Molecule Libraries | 2020 |
Progress report on the anorectic effects of dexfenfluramine, fluoxetine and sertraline.
Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain; Eating; Fenfluramine; Fluoxetine; Humans; Serotonin; Serotonin Antagonists; Sertraline | 1992 |
Pharmacokinetics of the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline | 1992 |
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.
Topics: 1-Naphthylamine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Neurotransmitter Uptake Inhibitors; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline | 1992 |
Pharmacotherapy of obsessive compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Paroxetine; Piperidines; Serotonin; Sertraline | 1992 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Clinical overview of serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Piperidines; Serotonin Antagonists; Sertraline; Zimeldine | 1990 |
Comparative pharmacokinetics of selective serotonin reuptake inhibitors: a look behind the mirror.
Topics: 1-Naphthylamine; Animals; Citalopram; Cytochrome P-450 Enzyme System; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereoisomerism | 1995 |
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
Selective serotonin reuptake inhibitors: pharmacologic profiles and potential therapeutic distinctions.
Topics: 1-Naphthylamine; Alcoholism; Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Depressive Disorder; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Pharmacologic treatment of rapid ejaculation.
Topics: 1-Naphthylamine; Adult; Clinical Trials as Topic; Clomipramine; Cyclohexanols; Dose-Response Relationship, Drug; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological; Venlafaxine Hydrochloride | 1995 |
Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder. A meta-analysis.
Topics: 1-Naphthylamine; Adolescent; Adult; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Multicenter Studies as Topic; Obsessive-Compulsive Disorder; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1995 |
Targeted pharmacotherapy in depression management: comparative pharmacokinetics of fluoxetine, paroxetine and sertraline.
Topics: 1-Naphthylamine; Depressive Disorder; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Half-Life; Humans; Metabolic Clearance Rate; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
The pharmacotherapy of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Buspirone; Clomipramine; Desipramine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
Management of recurrent depression.
Topics: 1-Naphthylamine; Antidepressive Agents; Chronic Disease; Combined Modality Therapy; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Imipramine; Paroxetine; Psychotherapy; Recurrence; Sertraline | 1993 |
[New antidepressive agents].
Topics: 1-Naphthylamine; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Benzamides; Child; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Moclobemide; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Does intolerance or lack of response with fluoxetine predict the same will happen with sertraline?
Topics: 1-Naphthylamine; Adolescent; Adult; Bipolar Disorder; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Use of serotonin selective reuptake inhibitors in geriatric depression.
Topics: 1-Naphthylamine; Age Factors; Aged; Controlled Clinical Trials as Topic; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Antidepressants in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clomipramine; Combined Modality Therapy; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Psychotherapy; Sertraline; Sexual Dysfunctions, Psychological | 1996 |
Hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone associated with the use of selective serotonin reuptake inhibitors: a review of spontaneous reports.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Female; Fluoxetine; Fluvoxamine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Middle Aged; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Depression: making the diagnosis and using SSRIs in the older patient.
Topics: 1-Naphthylamine; Adult; Aged; Alzheimer Disease; Depressive Disorder; Diagnosis, Differential; Dose-Response Relationship, Drug; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
A risk-benefit assessment of drugs used in the management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Buspirone; Child; Clomipramine; Clonazepam; Costs and Cost Analysis; Dopamine Antagonists; Drug Interactions; Drug Tolerance; Fenfluramine; Fluoxetine; Fluvoxamine; Humans; Lithium; Obsessive-Compulsive Disorder; Paroxetine; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Cytochrome P450 enzymes: interpretation of their interactions with selective serotonin reuptake inhibitors. Part II.
Topics: 1-Naphthylamine; Animals; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Interactions; Enzyme Induction; Enzyme Inhibitors; Fluoxetine; Fluvoxamine; Humans; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Movement disorders associated with the serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Age Factors; Aged; Akathisia, Drug-Induced; Depressive Disorder; Dyskinesia, Drug-Induced; Dystonia; Female; Fluoxetine; Fluvoxamine; Humans; Male; MEDLINE; Middle Aged; Parkinson Disease, Secondary; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 1996 |
The role of SSRIs in panic disorder.
Topics: 1-Naphthylamine; Citalopram; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Analytical methods for the quantitative determination of selective serotonin reuptake inhibitors for therapeutic drug monitoring purposes in patients.
Topics: 1-Naphthylamine; Chromatography; Citalopram; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride | 1997 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 1997 |
Pharmacokinetic drug interactions of new antidepressants: a review of the effects on the metabolism of other drugs.
Topics: 1-Naphthylamine; Antidepressive Agents; Cyclohexanols; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
Pharmacologic treatment of obsessive-compulsive disorder: comparative studies.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Clinical Trials as Topic; Clomipramine; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
The use of newer antidepressants for panic disorder.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Challenges in obesity management.
Topics: 1-Naphthylamine; Adrenergic beta-Agonists; Appetite Depressants; Behavior Therapy; Caffeine; Cyclobutanes; Diethylpropion; Ephedrine; Fenfluramine; Fluoxetine; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Phentermine; Proteins; Sertraline | 1998 |
Antidepressant response in late-life depression.
Topics: 1-Naphthylamine; Age Factors; Aged; Antidepressive Agents, Tricyclic; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Middle Aged; Nortriptyline; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1998 |
SSRI safety in overdose.
Topics: Adult; Child; Citalopram; Drug Overdose; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Poison Control Centers; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1998 |
Depression and dementia: comorbidities, identification, and treatment.
Topics: Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Benzamides; Citalopram; Clomipramine; Cognition Disorders; Comorbidity; Dementia; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Imipramine; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Neuropsychological Tests; Nortriptyline; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Current concepts in the treatment of panic disorder.
Topics: Antidepressive Agents, Tricyclic; Benzodiazepines; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Monoamine Oxidase Inhibitors; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Pharmacological treatment of premature ejaculation.
Topics: Antidepressive Agents, Tricyclic; Clomipramine; Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Dysfunction, Physiological | 1999 |
Pharmacokinetics of selective serotonin reuptake inhibitors.
Topics: Citalopram; Clinical Trials as Topic; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Antimicrobial activity of psychotropic drugs: selective serotonin reuptake inhibitors.
Topics: Anti-Bacterial Agents; Bacteria; Corynebacterium; Drug Synergism; Fluoxetine; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Premenstrual dysphoria and the serotonin system: pathophysiology and treatment.
Topics: Diagnosis, Differential; Female; Fluoxetine; Humans; Premenstrual Syndrome; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Terminology as Topic | 2000 |
Pharmacoeconomic studies of antidepressants: focus on venlafaxine.
Topics: Antidepressive Agents, Second-Generation; Buspirone; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclohexanols; Depressive Disorder; Drug Tolerance; Fluoxetine; Fluvoxamine; Humans; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Psychopharmacologic treatment of adolescent depression.
Topics: Adolescent; Child; Cyclohexanols; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2001 |
The effects of antidepressants on sexual functioning in depressed patients: a review.
Topics: Adult; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Sexuality; Single-Blind Method; Triazoles | 2001 |
Treating premenstrual dysphoric disorder using serotonin agents.
Topics: Female; Fluoxetine; Humans; Mood Disorders; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Serotonin agents in the treatment of acquired brain injury.
Topics: Brain Injuries; Citalopram; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Injury Severity Score; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
[Obsessive-compulsive disorders in general practice. How the obsessive-compulsive neurotic is revealed by skin and hair].
Topics: Adolescent; Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior Therapy; Child; Citalopram; Clomipramine; Depression; Diagnosis, Differential; Eczema; Family Practice; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Psychotherapy; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Time Factors; Trichotillomania | 2003 |
Treating functional impairment of autism with selective serotonin-reuptake inhibitors.
Topics: Autistic Disorder; Citalopram; Clinical Trials as Topic; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Clinical effects of pharmacological variations in selective serotonin reuptake inhibitors: an overview.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Fluoxetine; Fluvoxamine; Humans; Mood Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2005 |
Antidepressants and risk of upper gastrointestinal bleeding.
Topics: Adverse Drug Reaction Reporting Systems; Age Factors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antidepressive Agents; Blood Platelets; Drug Interactions; Epidemiologic Studies; Fluoxetine; Gastrointestinal Hemorrhage; Humans; Paroxetine; Platelet Aggregation; Risk Factors; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Upper Gastrointestinal Tract | 2006 |
Pharmacotherapy of child and adolescent depression.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Sertraline; Social Behavior | 2006 |
[Safety of selective serotonin reuptake inhibitor antidepressants in children and adolescents].
Topics: Adolescent; Adult; Age Factors; Antidepressive Agents, Second-Generation; Case-Control Studies; Child, Preschool; Citalopram; Confidence Intervals; Depressive Disorder; Family Practice; Female; Fluoxetine; Fluvoxamine; History, Medieval; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Placebos; Psychotherapy; Randomized Controlled Trials as Topic; Risk; Safety; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Suicide; Suicide, Attempted | 2006 |
Selective serotonin reuptake inhibitors (SSRIs) for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2007 |
[Trichotillomania: three cases presentation and diagnosis tests review].
Topics: Adolescent; Alopecia Areata; Child; Combined Modality Therapy; Diagnosis, Differential; Female; Fluoxetine; Humans; Psychotherapy; Sertraline; Trichotillomania | 2007 |
Comprehensive analysis of remission (COMPARE) with venlafaxine versus SSRIs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Citalopram; Cyclohexanols; Depressive Disorder, Major; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2008 |
Sustained response versus relapse: the pharmacotherapeutic goal for obsessive-compulsive disorder.
Topics: Clomipramine; Fluoxetine; Humans; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Randomized Controlled Trials as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2007 |
Use of medication in children with psychiatric disorders.
Topics: Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Child; Child Psychiatry; Drug Prescriptions; Drug Utilization; Fluoxetine; Fluvoxamine; Health Policy; Humans; Melatonin; Mental Disorders; Methylphenidate; Needs Assessment; Patient Selection; Practice Guidelines as Topic; Practice Patterns, Physicians'; Propylamines; Psychotropic Drugs; Risperidone; Sertraline; United Kingdom | 2007 |
Emerging concepts in the medical and surgical treatment of obesity.
Topics: Adipose Tissue; Amyloid; Anticonvulsants; Antidepressive Agents; Anxiety; Appetite Regulation; Bariatric Surgery; Body Mass Index; Bupropion; Cholecystokinin; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Cyclobutanes; Depression; Diabetes Mellitus, Type 2; Female; Fluoxetine; Fructose; Ghrelin; Humans; Intra-Abdominal Fat; Islet Amyloid Polypeptide; Isoxazoles; Lactones; Leptin; Metabolic Syndrome; Metformin; Obesity; Obesity, Morbid; Orlistat; Oxyntomodulin; Peptide YY; Piperidines; Polycystic Ovary Syndrome; Pyrazoles; Rimonabant; Sertraline; Sleep Apnea, Obstructive; Surgical Procedures, Operative; Topiramate; Zonisamide | 2008 |
Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis.
Topics: Adult; Citalopram; Female; Fluoxetine; Fluvoxamine; Humans; Odds Ratio; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2008 |
Antidepressant medication use during breastfeeding.
Topics: Antidepressive Agents, Second-Generation; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Humans; Infant; Lactation; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Are typical starting doses of the selective serotonin reuptake inhibitors sub-optimal? A meta-analysis of randomized, double-blind, placebo-controlled, dose-finding studies in major depressive disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Remission with mirtazapine and selective serotonin reuptake inhibitors: a meta-analysis of individual patient data from 15 controlled trials of acute phase treatment of major depression.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antidepressive Agents, Tricyclic; Citalopram; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Patient Dropouts; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2010 |
Selective serotonin-reuptake inhibitors in the treatment of panic disorder: a systematic review of placebo-controlled studies.
Topics: Citalopram; Double-Blind Method; Fluoxetine; Fluvoxamine; Humans; Panic Disorder; Paroxetine; Placebo Effect; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Use of selective serotonin reuptake inhibitors during pregnancy and risk of major and cardiovascular malformations: an update.
Topics: Abnormalities, Drug-Induced; Cardiovascular Abnormalities; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Humans; Maternal-Fetal Exchange; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Teratogens | 2010 |
[Selective serotonin reuptake inhibitors and mammary pathologies].
Topics: Antidepressive Agents; Breast Neoplasms; Citalopram; Clinical Trials as Topic; Female; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Post-traumatic stress disorder.
Topics: Antidepressive Agents; Fluoxetine; Humans; Psychotherapy, Psychodynamic; Sertraline; Stress Disorders, Post-Traumatic | 2010 |
Selective serotonin reuptake inhibitors (SSRIs): therapeutic drug monitoring and pharmacological interactions.
Topics: Benzofurans; Citalopram; Depressive Disorder; Drug Monitoring; Fluoxetine; Fluvoxamine; Humans; Indoles; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Vilazodone Hydrochloride | 2012 |
Newer generation antidepressants for depressive disorders in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Fluoxetine; Humans; Induction Chemotherapy; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2012 |
Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery.
Topics: Adult; Anxiety; Citalopram; Cognition; Depression; Fluoxetine; Humans; Nervous System Diseases; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke; Stroke Rehabilitation | 2012 |
The efficacy and tolerability of SSRI/SNRIs in the treatment of vasomotor symptoms in menopausal women: a systematic review.
Topics: Adult; Aged; Citalopram; Desvenlafaxine Succinate; Female; Fluoxetine; Hot Flashes; Humans; Menopause; Middle Aged; Paroxetine; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Vasomotor System; Venlafaxine Hydrochloride | 2015 |
A systematic review of Chinese randomized clinical trials of SSRI treatment of depression.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; China; Citalopram; Depressive Disorder; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Antidepressant treatment for postnatal depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Depression, Postpartum; Female; Fluoxetine; Humans; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults.
Topics: Adrenergic Uptake Inhibitors; Adult; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Humans; Norepinephrine; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Tension-Type Headache; Venlafaxine Hydrochloride | 2015 |
Systematic Review and Meta-Analysis: Dose-Response Relationship of Selective Serotonin Reuptake Inhibitors in Major Depressive Disorder.
Topics: Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2016 |
Antidepressants for treating depression in adults with end-stage kidney disease treated with dialysis.
Topics: Adult; Antidepressive Agents; Citalopram; Depression; Fluoxetine; Humans; Kidney Failure, Chronic; Psychotherapy; Quality of Life; Randomized Controlled Trials as Topic; Renal Dialysis; Sertraline | 2016 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Dose Escalation of Antidepressants in Unipolar Depression: A Meta-Analysis of Double-Blind, Randomized Controlled Trials.
Topics: Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2017 |
Effects of waterborne antidepressants on non-target animals living in the aquatic environment: A review.
Topics: Animals; Antidepressive Agents; Aquatic Organisms; Fishes; Fluoxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Water Pollutants, Chemical | 2018 |
Antidepressant pharmacogenetics in children and young adults: A systematic review.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2D6; Female; Fluoxetine; Fluvoxamine; Humans; Male; Mental Disorders; Nortriptyline; Paroxetine; Pharmacogenetics; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tryptophan Hydroxylase; Venlafaxine Hydrochloride; Young Adult | 2019 |
Comparative cardiovascular safety of selective serotonin reuptake inhibitors (SSRIs) among Chinese senile depression patients: A network meta-analysis of randomized controlled trials.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Asian People; Cardiovascular Diseases; China; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2019 |
Exploring the utility of RDoC in differentiating effectiveness amongst antidepressants: A systematic review using proposed psychometrics as the unit of analysis for the Negative Valence Systems domain.
Topics: Algorithms; Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depressive Disorder; Desvenlafaxine Succinate; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Psychometrics; Sertraline; Treatment Outcome | 2020 |
New generation antidepressants for depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Antidepressive Agents; Bias; Child; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mirtazapine; Network Meta-Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicidal Ideation; Venlafaxine Hydrochloride; Vilazodone Hydrochloride; Vortioxetine | 2021 |
Are all antidepressants the same? The consumer has a point.
Topics: Antidepressive Agents; Bupropion; Citalopram; Fluoxetine; Humans; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2023 |
Comparison of fluoxetine with other selective serotonin reuptake inhibitors in the treatment of premature ejaculation: A systematic review and meta-analysis.
Topics: Ejaculation; Fluoxetine; Humans; Male; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2022 |
Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Topics: Adult; Amitriptyline; Antidepressive Agents; Citalopram; Depressive Disorder, Major; Desvenlafaxine Succinate; Duloxetine Hydrochloride; Female; Fluoxetine; Fluvoxamine; Humans; Mirtazapine; Network Meta-Analysis; Paroxetine; Randomized Controlled Trials as Topic; Reboxetine; Sertraline; Venlafaxine Hydrochloride; Vortioxetine | 2023 |
Benefits and Risks of Antidepressant Drugs During Pregnancy: A Systematic Review of Meta-analyses.
Topics: Antidepressive Agents; Child; Female; Fluoxetine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Premature Birth; Risk Assessment; Sertraline | 2023 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
75 trial(s) available for fluoxetine and sertraline
| Article | Year |
|---|---|
Drug treatment of canine acral lick. An animal model of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Animals; Clomipramine; Dermatitis; Desipramine; Disease Models, Animal; Dog Diseases; Dogs; Double-Blind Method; Fenfluramine; Fluoxetine; Follow-Up Studies; Grooming; Humans; Neurotransmitter Uptake Inhibitors; Obsessive-Compulsive Disorder; Serotonin; Sertraline; Ulcer | 1992 |
Are patients who are intolerant to one SSRI intolerant to another?
Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Drug Tolerance; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1992 |
A controlled trial of fluvoxamine in obsessive-compulsive disorder: implications for a serotonergic theory.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Clinical Trials as Topic; Clomipramine; Double-Blind Method; Female; Fluoxetine; Fluvoxamine; Humans; Male; Meta-Analysis as Topic; Obsessive-Compulsive Disorder; Oximes; Placebos; Psychiatric Status Rating Scales; Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Selective serotonin reuptake inhibitor-induced sexual dysfunction: efficacy of a drug holiday.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological | 1995 |
Clinical effect of converting antidepressant therapy from fluoxetine to sertraline.
Topics: 1-Naphthylamine; Ambulatory Care; Antidepressive Agents; Depression; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Sertraline; Single-Blind Method | 1995 |
Are patients who are intolerant to one serotonin selective reuptake inhibitor intolerant to another?
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Tolerance; Female; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1995 |
Sertraline pharmacotherapy for paraphilias and paraphilia-related disorders: an open trial.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Fluoxetine; Humans; Male; Middle Aged; Paraphilic Disorders; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Behavior; Treatment Outcome | 1994 |
Childhood psychopathology retrospectively assessed among adults with early onset major depression.
Topics: 1-Naphthylamine; Adolescent; Adult; Anxiety Disorders; Child; Child Behavior Disorders; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Imipramine; Male; Mental Disorders; Middle Aged; Paroxetine; Personality Development; Phobic Disorders; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Pharmacokinetics of desipramine coadministered with sertraline or fluoxetine.
Topics: 1-Naphthylamine; Antidepressive Agents; Chromatography, High Pressure Liquid; Desipramine; Dextromethorphan; Drug Interactions; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Double-blind study of the efficacy and safety of sertraline versus fluoxetine in major depression.
Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1993 |
Response to an open trial of a second SSRI in major depression.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Clinical and biochemical effects of catecholamine depletion on antidepressant-induced remission of depression.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Antidepressive Agents; Brain; Brain Chemistry; Depressive Disorder; Desipramine; Diphenhydramine; Dopamine; Fluoxetine; Humans; Mazindol; Methyltyrosines; Norepinephrine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Fluoxetine treatment of patients with major depressive disorder who failed initial treatment with sertraline.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Humans; Male; Prospective Studies; Psychiatric Status Rating Scales; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Failure; Treatment Outcome | 1997 |
Selective serotonin reuptake inhibitor treatment of depression in symptomatic HIV infection and AIDS. Improvements in affective and somatic symptoms.
Topics: 1-Naphthylamine; Acquired Immunodeficiency Syndrome; Adaptation, Psychological; Adult; Depressive Disorder; Female; Fluoxetine; HIV Infections; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Sick Role; Somatoform Disorders | 1997 |
Six month follow-up of early-onset chronic depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chronic Disease; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Patient Discharge; Prognosis; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Compulsive Behavior; Dementia; Depressive Disorder; Female; Fluoxetine; Frontal Lobe; Humans; Impulsive Behavior; Male; Middle Aged; Paroxetine; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Temporal Lobe; Treatment Outcome | 1997 |
Effects of serotonin reuptake inhibitors on aggressive behavior in psychiatrically hospitalized adolescents: results of an open trial.
Topics: 1-Naphthylamine; Adolescent; Aggression; Female; Fluoxetine; Humans; Inpatients; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Addition of desipramine to serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Adrenergic Uptake Inhibitors; Adult; Clomipramine; Desipramine; Double-Blind Method; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Sexual Dysfunctions, Psychological; Surveys and Questionnaires | 1997 |
Use of SSRIs in "very old" depressed nursing home residents.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Alzheimer Disease; Central Nervous System Diseases; Dementia, Vascular; Depressive Disorder; Female; Fluoxetine; Homes for the Aged; Humans; Male; Matched-Pair Analysis; New York; Nursing Homes; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Statistics, Nonparametric | 1998 |
Serotonin reuptake antidepressant effects on sexual function in patients with anxiety disorders.
Topics: 1-Naphthylamine; Adult; Anxiety; Ejaculation; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Orgasm; Paroxetine; Penile Erection; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological | 1998 |
Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Half-Life; Health Status; Humans; Male; Middle Aged; Paroxetine; Placebos; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Substance Withdrawal Syndrome; Surveys and Questionnaires | 1998 |
Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo controlled study.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Tricyclic; Clomipramine; Double-Blind Method; Ejaculation; Fluoxetine; Humans; Male; Patient Satisfaction; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 1998 |
Effect of SSRI antidepressants on ejaculation: a double-blind, randomized, placebo-controlled study with fluoxetine, fluvoxamine, paroxetine, and sertraline.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Double-Blind Method; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Paroxetine; Reaction Time; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Clinical and economic comparison of sertraline and fluoxetine in the treatment of depression. A 6-month double-blind study in a primary-care setting in France.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Antidepressive Agents; Costs and Cost Analysis; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; France; Humans; Male; Middle Aged; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
CYP2D6 status of extensive metabolizers after multiple-dose fluoxetine, fluvoxamine, paroxetine, or sertraline.
Topics: Adult; Cytochrome P-450 CYP2D6; Dextromethorphan; Dextrorphan; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Reference Values; Sertraline | 1999 |
Comparative efficacy of sertraline vs. fluoxetine in patients age 70 or over with major depression.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Neuropsychological Tests; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Weight Loss | 1999 |
Antidepressant medication change in a clinical treatment setting: a comparison of the effectiveness of selective serotonin reuptake inhibitors.
Topics: Adolescent; Adult; Aged; Antidepressive Agents, Tricyclic; Anxiety Disorders; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Medical Records; Mental Disorders; Middle Aged; Mood Disorders; Paroxetine; Retrospective Studies; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Predictors of an acute antidepressant response to fluoxetine and sertraline.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Forecasting; Humans; Male; Middle Aged; Motor Activity; Prognosis; Regression Analysis; Sertraline; Treatment Outcome | 1999 |
A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.
Topics: Adolescent; Adult; Aged; Ambulatory Care; Depressive Disorder, Major; Double-Blind Method; Drug Tolerance; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 1999 |
Antidepressant treatment of depression in HIV-seropositive women.
Topics: Ambulatory Care; Antidepressive Agents; Comorbidity; Depressive Disorder; Female; Fluoxetine; HIV Seropositivity; Humans; Psychiatric Status Rating Scales; Sertraline; Sex Factors; Treatment Outcome | 1999 |
CYP2D6 inhibition by fluoxetine, paroxetine, sertraline, and venlafaxine in a crossover study: intraindividual variability and plasma concentration correlations.
Topics: Chromatography, High Pressure Liquid; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Humans; Isoenzymes; Paroxetine; Phenotype; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation.
Topics: Adult; Ejaculation; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 1999 |
Hormonal markers of stress response following interruption of selective serotonin reuptake inhibitor treatment.
Topics: Adult; Biomarkers; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Hemodynamics; Hormones; Humans; Male; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress, Psychological; Substance Withdrawal Syndrome | 2000 |
Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dysthymic Disorder; Female; Fluoxetine; Humans; Immune Tolerance; Lymphocyte Activation; Male; Middle Aged; Paroxetine; Personality Inventory; Sertraline; Venlafaxine Hydrochloride | 2000 |
On the pharmacotherapy of obsessive-compulsive disorder: is a consensus possible?
Topics: Clomipramine; Double-Blind Method; Expert Testimony; Fluoxetine; Fluvoxamine; Guidelines as Topic; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Fluoxetine versus sertraline and paroxetine in major depression: tolerability and efficacy in anxious depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Comparison of moclobemide with selective serotonin reuptake inhibitors (SSRIs) on sexual function in depressed adults. The Australian and German Study Groups.
Topics: Adult; Antidepressive Agents; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Moclobemide; Monoamine Oxidase Inhibitors; Paroxetine; Prospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires; Time Factors | 2000 |
A double-blind comparison of sertraline and fluoxetine in depressed elderly outpatients.
Topics: Age Factors; Aged; Ambulatory Care; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Fluoxetine versus sertraline and paroxetine in major depressive disorder: changes in weight with long-term treatment.
Topics: Adult; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Paroxetine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2000 |
Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive disorder.
Topics: Adult; Ambulatory Care; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method; Treatment Outcome | 2000 |
Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline.
Topics: Age of Onset; Aged; Antidepressive Agents; Anxiety; Cardiovascular Diseases; Comorbidity; Depressive Disorder; Double-Blind Method; Female; Fluoxetine; Humans; Hypertension; Male; Mental Status Schedule; Middle Aged; Nortriptyline; Patient Selection; Placebos; Psychiatric Status Rating Scales; Safety; Sertraline; Vascular Diseases | 2001 |
Similar effectiveness of paroxetine, fluoxetine, and sertraline in primary care: a randomized trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Psychiatric Status Rating Scales; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2001 |
Acute efficacy of fluoxetine versus sertraline and paroxetine in major depressive disorder including effects of baseline insomnia.
Topics: Acute Disease; Adverse Drug Reaction Reporting Systems; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Fluoxetine; Humans; Paroxetine; Personality Inventory; Sertraline; Sleep Initiation and Maintenance Disorders; Treatment Outcome | 2002 |
Sertraline and fluoxetine treatment of obsessive-compulsive disorder: results of a double-blind, 6-month treatment study.
Topics: Adolescent; Adult; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Differential time course of cytochrome P450 2D6 enzyme inhibition by fluoxetine, sertraline, and paroxetine in healthy volunteers.
Topics: Adolescent; Adult; Cytochrome P-450 CYP2D6 Inhibitors; Female; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 2002 |
Switching patients from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine in the maintenance of response for depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder, Major; Drug Administration Schedule; Female; Fluoxetine; Humans; Male; Middle Aged; Outcome Assessment, Health Care; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2002 |
CYP2D6 inhibition by selective serotonin reuptake inhibitors: analysis of achievable steady-state plasma concentrations and the effect of ultrarapid metabolism at CYP2D6.
Topics: Cyclooxygenase Inhibitors; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Dextromethorphan; Dextrorphan; Fluoxetine; Fluvoxamine; Genotype; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Adjunctive olanzapine for SSRI-resistant combat-related PTSD: a double-blind, placebo-controlled study.
Topics: Antipsychotic Agents; Benzodiazepines; Combat Disorders; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fluoxetine; Humans; Male; Middle Aged; Olanzapine; Paroxetine; Pirenzepine; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders; Treatment Outcome | 2002 |
Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report.
Topics: Adrenergic Uptake Inhibitors; Adult; Amitriptyline; Anorexia Nervosa; Body Mass Index; Dopamine Antagonists; Drug Therapy, Combination; Female; Fluoxetine; Haloperidol; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2003 |
Does antidepressant therapy improve cognition in elderly depressed patients?
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Cognition; Cognition Disorders; Confidence Intervals; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Nortriptyline; Probability; Reference Values; Sertraline; Severity of Illness Index; Single-Blind Method; Statistics, Nonparametric; Treatment Outcome | 2003 |
Comparative CYP3A4 inhibitory effects of venlafaxine, fluoxetine, sertraline, and nefazodone in healthy volunteers.
Topics: Administration, Oral; Adult; Alprazolam; Area Under Curve; Breath Tests; Carbon Radioisotopes; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Delayed-Action Preparations; Drug Administration Schedule; Erythromycin; Fluoxetine; Half-Life; Humans; Male; Middle Aged; Molecular Probes; Piperazines; Sertraline; Triazoles; Venlafaxine Hydrochloride | 2004 |
Pindolol augmentation in depressed patients resistant to selective serotonin reuptake inhibitors: a double-blind, randomized, controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Connecticut; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Hospitals, Veterans; Humans; Male; Middle Aged; Paroxetine; Personality Inventory; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Veterans | 2004 |
The outcome of physical symptoms with treatment of depression.
Topics: Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Health Status; Health Surveys; Humans; Male; Middle Aged; Paroxetine; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sertraline; Somatoform Disorders; Treatment Outcome | 2004 |
Weight gain during long-term treatment of obsessive-compulsive disorder: a prospective comparison between serotonin reuptake inhibitors.
Topics: Adult; Ambulatory Care; Citalopram; Clomipramine; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Male; Obesity; Obsessive-Compulsive Disorder; Paroxetine; Patient Compliance; Prospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2004 |
Trauma, resilience and saliostasis: effects of treatment in post-traumatic stress disorder.
Topics: Adaptation, Psychological; Adult; Cognitive Behavioral Therapy; Female; Fluoxetine; GABA Agonists; Humans; Male; Middle Aged; Nipecotic Acids; Prognosis; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Stress Disorders, Post-Traumatic; Tiagabine; Treatment Outcome | 2005 |
Selective serotonin reuptake inhibitors treatment effects on auditory measures in depressed female subjects.
Topics: Acoustic Impedance Tests; Adult; Brain; Depression; Dichotic Listening Tests; Evoked Potentials, Auditory, Brain Stem; Female; Fluoxetine; Humans; Loudness Perception; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Speech Perception | 2005 |
Response of emotional unawareness after stroke to antidepressant treatment.
Topics: Activities of Daily Living; Affective Symptoms; Aged; Agnosia; Antidepressive Agents; Awareness; Cognition; Depressive Disorder, Major; Emotions; Fluoxetine; Follow-Up Studies; Humans; Internal-External Control; Mental Status Schedule; Personality Inventory; Sertraline; Stroke | 2006 |
Fluoxetine versus sertraline in the treatment of patients with undifferentiated somatoform disorder: a randomized, open-label, 12-week, parallel-group trial.
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Health Status; Humans; Male; Personality Inventory; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Somatoform Disorders; Surveys and Questionnaires; Treatment Outcome | 2008 |
The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents; Aripiprazole; Citalopram; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Fatigue; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Piperazines; Prospective Studies; Psychiatric Status Rating Scales; Quinolones; Sertraline; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Weight Gain; Withholding Treatment | 2008 |
A randomized, double-blind trial comparing sertraline and fluoxetine 6-month treatment in obese patients with Binge Eating Disorder.
Topics: Adult; Body Mass Index; Bulimia Nervosa; Double-Blind Method; Female; Fluoxetine; Humans; Middle Aged; Obesity; Prospective Studies; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires; Treatment Outcome | 2008 |
The pharmacokinetics of standard antidepressants with aripiprazole as adjunctive therapy: studies in healthy subjects and in patients with major depressive disorder.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Double-Blind Method; Drug Interactions; Female; Fluoxetine; Humans; Male; Middle Aged; Piperazines; Quinolones; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride; Young Adult | 2010 |
Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules.
Topics: Adult; Aged; Aorta; Cell Adhesion; Cell Survival; Chronic Disease; Citalopram; Depression; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fluoxetine; Fluvoxamine; Heart Failure; Humans; Intercellular Adhesion Molecule-1; Middle Aged; Monocytes; Placebos; Selective Serotonin Reuptake Inhibitors; Sertraline; Tumor Necrosis Factor-alpha; U937 Cells; Vascular Cell Adhesion Molecule-1 | 2010 |
Effects of SNS activation on SSRI-induced sexual side effects differ by SSRI.
Topics: Adrenergic Agents; Adult; Arousal; Cross-Over Studies; Depressive Disorder; Double-Blind Method; Ephedrine; Female; Fluoxetine; Humans; Norepinephrine; Orgasm; Paroxetine; Premedication; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Sexual Behavior; Sexual Dysfunction, Physiological; Sympathetic Nervous System | 2009 |
Effects of selective serotonin reuptake inhibitors on thyroid function in depressed patients with primary hypothyroidism or normal thyroid function.
Topics: Adult; Aged; Autoantibodies; Depressive Disorder, Major; Fluoxetine; Humans; Hypothyroidism; Iodide Peroxidase; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Function Tests; Thyroid Gland; Thyrotropin; Thyroxine; Triiodothyronine | 2009 |
Depression and comorbid panic in primary care patients.
Topics: Adult; Comorbidity; Depressive Disorder; Female; Fluoxetine; Humans; Longitudinal Studies; Male; Middle Aged; Multicenter Studies as Topic; Panic Disorder; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2010 |
Topiramate augmentation in patients with resistant major depressive disorder: a double-blind placebo-controlled clinical trial.
Topics: Adult; Citalopram; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Fluoxetine; Fructose; Humans; Male; Neuroprotective Agents; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate | 2011 |
Relevance of serum nitric oxide levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation: decreased nitric oxide is associated with premature ejaculation.
Topics: Adult; Case-Control Studies; Female; Fluoxetine; Humans; Male; Middle Aged; Nitric Oxide; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2014 |
Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Adult; Fluoxetine; Humans; Male; Melatonin; Middle Aged; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Young Adult | 2014 |
Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial.
Topics: Adult; Carotenoids; Citalopram; Crocus; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Iran; Male; Middle Aged; Phytotherapy; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Influence of ACE gene on differential response to sertraline versus fluoxetine in patients with major depression: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Alleles; Antidepressive Agents; Depressive Disorder, Major; Female; Fluoxetine; Genotype; Humans; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Sertraline; Young Adult | 2016 |
[The Effectiveness of Cognitive Behavioral Therapy, Medication, or Combined Treatment For Child Hood Anxiety Disorders].
Topics: Anti-Anxiety Agents; Anxiety Disorders; Child; Cognitive Behavioral Therapy; Combined Modality Therapy; Female; Fluoxetine; Humans; Hydroxyzine; Male; Psychiatric Status Rating Scales; Sertraline; Treatment Outcome | 2016 |
A randomised controlled trial assessing the use of citalopram, sertraline, fluoxetine and mirtazapine in preventing relapse in primary care patients who are taking long-term maintenance antidepressants (ANTLER: ANTidepressants to prevent reLapse in dEpRes
Topics: Adult; Aged; Antidepressive Agents; Citalopram; Cost-Benefit Analysis; Depression; Double-Blind Method; Fluoxetine; Humans; Middle Aged; Mirtazapine; Outcome Assessment, Health Care; Primary Health Care; Randomized Controlled Trials as Topic; Recurrence; Retrospective Studies; Sample Size; Sertraline | 2019 |
[Fluvoxamine in the treatment of depressive disorders in alcohol dependence: results of randomized open-label comparative study].
Topics: Alcoholism; Citalopram; Depressive Disorder; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
Predictors of response to pharmacotherapy in children and adolescents with psychiatric disorders: A combined post hoc analysis of four clinical trial data.
Topics: Adolescent; Child; Depressive Disorder, Major; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2022 |
334 other study(ies) available for fluoxetine and sertraline
| Article | Year |
|---|---|
Pyrroloisoquinoline antidepressants. 2. In-depth exploration of structure-activity relationships.
Topics: Animals; Antidepressive Agents; Blepharoptosis; Brain; Catecholamines; Chemical Phenomena; Chemistry; Dopamine; Isoquinolines; Male; Molecular Conformation; Motor Activity; Norepinephrine; Pyrroles; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Serotonin; Serotonin; Structure-Activity Relationship; Synaptosomes; Tetrabenazine | 1987 |
Molecular structure of fluoxetine hydrochloride, a highly selective serotonin-uptake inhibitor.
Topics: Animals; Brain; Fluoxetine; Kinetics; Models, Molecular; Molecular Conformation; Norepinephrine; Propylamines; Rats; Serotonin; Serotonin Antagonists; Synaptosomes; X-Ray Diffraction | 1988 |
Synthesis of a potent wide-spectrum serotonin-, norepinephrine-, dopamine-reuptake inhibitor (SNDRI) and a species-selective dopamine-reuptake inhibitor based on the gamma-amino alcohol functional group.
Topics: Amino Alcohols; Animals; Antidepressive Agents; Dopamine; Humans; Neurotransmitter Uptake Inhibitors; Norepinephrine; Rats; Serotonin; Species Specificity | 1998 |
Inhibition of P-glycoprotein by newer antidepressants.
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Endothelium, Vascular; Humans; Reproducibility of Results; Swine; Transfection | 2003 |
Carbonic anhydrase activators. The selective serotonin reuptake inhibitors fluoxetine, sertraline and citalopram are strong activators of isozymes I and II.
Topics: Brain; Carbonic Anhydrase I; Carbonic Anhydrase II; Citalopram; Crystallography, X-Ray; Enzyme Activation; Enzyme Activators; Fluoxetine; Histamine; Phenylalanine; Selective Serotonin Reuptake Inhibitors; Sertraline; Structure-Activity Relationship | 2003 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
An antidepressant that extends lifespan in adult Caenorhabditis elegans.
Topics: Aging; Animals; Antidepressive Agents; Caenorhabditis elegans; Caloric Restriction; Humans; Longevity; Methiothepin; Mianserin; Octopamine; Receptors, Biogenic Amine; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin 5-HT4 Receptor Antagonists; Serotonin Antagonists; Signal Transduction; Starvation | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
Synthesis and pharmacological evaluation of 4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalenyl amines as triple reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Mice; Naphthalenes; Neurotransmitter Uptake Inhibitors; Norepinephrine; Serotonin | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.
Topics: Animals; Antidepressive Agents; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Drug Design; Humans; Imidazoles; Male; Mice; Motor Activity; Piperazines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Antagonists; Serotonin Plasma Membrane Transport Proteins; Stereoisomerism; Structure-Activity Relationship | 2011 |
Fluorescent reporters of monoamine transporter distribution and function.
Topics: Animals; Blood Pressure; Cell Line; Fluorescent Dyes; Isoquinolines; Mice; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Spectrophotometry, Ultraviolet | 2011 |
Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Topics: Artificial Intelligence; Calcium Channel Blockers; Calcium Channels, L-Type; Cell Line; Computational Biology; Computer Simulation; Drugs, Investigational; Ether-A-Go-Go Potassium Channels; Expert Systems; Heart Rate; Humans; Models, Biological; Myocytes, Cardiac; NAV1.5 Voltage-Gated Sodium Channel; Potassium Channel Blockers; Quantitative Structure-Activity Relationship; Risk Assessment; Shaker Superfamily of Potassium Channels; Torsades de Pointes; Voltage-Gated Sodium Channel Blockers | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Discovery and characterization of novel, potent, and selective cytochrome P450 2J2 inhibitors.
Topics: Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2J2; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Discovery; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Kinetics; Microsomes, Liver; Models, Molecular; Molecular Dynamics Simulation; Substrate Specificity | 2013 |
Combination treatment with noradrenalin and serotonin reuptake inhibitors in resistant depression.
Topics: 1-Naphthylamine; Adult; Aged; Aged, 80 and over; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Middle Aged; Nortriptyline; Receptors, Adrenergic; Receptors, Serotonin; Recurrence; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1992 |
The effect of selective serotonin re-uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sparteine | 1992 |
Serotonin as a regulator of craniofacial morphogenesis: site specific malformations following exposure to serotonin uptake inhibitors.
Topics: 1-Naphthylamine; Abnormalities, Drug-Induced; Amitriptyline; Animals; Cell Death; Cell Division; Epithelium; Facial Bones; Female; Fluoxetine; Mice; Mice, Inbred ICR; Morphogenesis; Pinocytosis; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Skull; Yolk Sac | 1992 |
If at first you do succeed.
Topics: 1-Naphthylamine; Antidepressive Agents; Benzamides; Depression; Fluoxetine; Half-Life; Humans; Moclobemide; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1991 |
[3H] sertraline binding to rat brain membranes.
Topics: 1-Naphthylamine; Animals; Brain; Fenclonine; Fluoxetine; Imipramine; In Vitro Techniques; Male; Membranes; Naphthalenes; Paroxetine; Piperidines; Rats; Receptors, Serotonin; Serotonin Antagonists; Sertraline | 1990 |
Quantitative autoradiography of serotonin uptake sites in rat brain using [3H]cyanoimipramine.
Topics: 1-Naphthylamine; Animals; Autoradiography; Binding, Competitive; Brain; Fluoxetine; Imipramine; Kinetics; Male; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sertraline; Zimeldine | 1988 |
Chronic idiopathic urticaria associated with panic disorder: a syndrome responsive to selective serotonin reuptake inhibitor antidepressants?
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Chronic Disease; Female; Fluoxetine; Humans; Middle Aged; Panic Disorder; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Urticaria | 1995 |
Postmarketing surveillance by patient self-monitoring: preliminary data for sertraline versus fluoxetine.
Topics: 1-Naphthylamine; Adult; Adverse Drug Reaction Reporting Systems; Aggression; Ambulatory Care; Confidence Intervals; Data Collection; Drug Monitoring; Female; Fluoxetine; Health Status; Humans; Male; Middle Aged; Patient Compliance; Probability; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Self Care; Sertraline; Telephone; Weight Gain | 1995 |
Acute uptake inhibition increases extracellular serotonin in the rat forebrain.
Topics: 1-Naphthylamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Corpus Striatum; Diencephalon; Fenfluramine; Fluoxetine; Hydroxyindoleacetic Acid; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1993 |
The effects of single and repeated anorectic doses of 5-hydroxytryptamine uptake inhibitors on indole levels in rat brain.
Topics: 1-Naphthylamine; Animals; Appetite Depressants; Brain Chemistry; Eating; Fluoxetine; Fluvoxamine; Hydroxyindoleacetic Acid; Indoles; Male; Paroxetine; Rats; Rats, Inbred Strains; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 1993 |
Isolation-induced aggression in mice: effects of 5-hydroxytryptamine uptake inhibitors and involvement of postsynaptic 5-HT1A receptors.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; 8-Hydroxy-2-(di-n-propylamino)tetralin; Aggression; Analysis of Variance; Animals; Behavior, Animal; Brain; Citalopram; Dose-Response Relationship, Drug; Fenclonine; Fluoxetine; Fluvoxamine; Male; Mice; Paroxetine; Penbutolol; Piperidines; Rats; Rats, Wistar; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Selective Serotonin Reuptake Inhibitors; Sertraline; Synaptosomes | 1994 |
SIADH associated with fluoxetine and sertraline therapy.
Topics: 1-Naphthylamine; Age Factors; Aged; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Inappropriate ADH Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Sodium | 1995 |
Serotonin reuptake inhibitors in Raynaud's phenomenon.
Topics: 1-Naphthylamine; Adult; Aged; Cyclohexanols; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Raynaud Disease; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1995 |
Attenuation of response to serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Drug Therapy, Combination; Drug Tolerance; Female; Fluoxetine; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Realities of the fluoxetine-to-sertraline switch.
Topics: 1-Naphthylamine; Cost-Benefit Analysis; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Tablets | 1995 |
Realities of the fluoxetine-to-sertraline switch.
Topics: 1-Naphthylamine; Dosage Forms; Fluoxetine; Humans; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Therapeutic Equivalency | 1995 |
Serotonin uptake inhibitors modulate intracellular Ca2+ mobilization in platelets.
Topics: 1-Naphthylamine; Blood Platelets; Calcium; Calmodulin; Cells, Cultured; Fluoxetine; Humans; Imipramine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Therapeutic interchange of fluoxetine and sertraline: experience in the clinical setting.
Topics: 1-Naphthylamine; Antidepressive Agents; Drug Costs; Fluoxetine; Humans; Organizational Policy; Pharmacy Service, Hospital; Selective Serotonin Reuptake Inhibitors; Sertraline; Therapeutic Equivalency | 1994 |
The use of serotonergic uptake inhibitors in the treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Ejaculation; Fluoxetine; Humans; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 1994 |
The use of serotonin reuptake inhibitors for the treatment of recurrent syncope due to carotid sinus hypersensitivity unresponsive to dual chamber cardiac pacing.
Topics: 1-Naphthylamine; Aged; Cardiac Pacing, Artificial; Carotid Sinus; Fluoxetine; Follow-Up Studies; Heart Arrest; Humans; Hypotension, Orthostatic; Male; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Syncope; Vasodilation | 1994 |
Valproate pretreatment for the difficult-to-treat patient with OCD.
Topics: 1-Naphthylamine; Antidepressive Agents; Clomipramine; Drug Therapy, Combination; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Paroxetine; Sertraline; Treatment Outcome; Valproic Acid | 1994 |
Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55.
Topics: 1-Naphthylamine; Animals; Binding, Competitive; Brain Chemistry; Carrier Proteins; Cocaine; Fluoxetine; Hypothalamus; Iodine Radioisotopes; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 1994 |
Neuronal monoamine reuptake inhibitors enhance in vitro susceptibility to chloroquine in resistant Plasmodium falciparum.
Topics: 1-Naphthylamine; Animals; Chloroquine; Desipramine; Drug Resistance; Drug Synergism; Fluoxetine; Neurotransmitter Uptake Inhibitors; Plasmodium falciparum; Sertraline | 1994 |
Pharmacologic management of obsessive-compulsive disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Anxiety Disorders; Clomipramine; Depression; Dopamine; Fluoxetine; Fluvoxamine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Synaptic Transmission; Trazodone | 1994 |
Is it safe to combine a selective serotonin reuptake inhibitor with selegiline?
Topics: 1-Naphthylamine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Parkinson Disease; Paroxetine; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline | 1994 |
Tolerance to fluoxetine.
Topics: 1-Naphthylamine; Adult; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug Tolerance; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline | 1993 |
SSRI-associated nocturnal bruxism in four patients.
Topics: 1-Naphthylamine; Adult; Bruxism; Buspirone; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep | 1993 |
Serotonin reuptake blockers for the treatment of obsessional jealousy.
Topics: 1-Naphthylamine; Adult; Clomipramine; Drug Therapy, Combination; Female; Fluoxetine; Humans; Jealousy; Male; Obsessive-Compulsive Disorder; Pimozide; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1994 |
Serotonin syndrome and drug interactions.
Topics: 1-Naphthylamine; Drug Interactions; Fluoxetine; Humans; Male; Serotonin; Sertraline | 1993 |
Serotonin and cardiac morphogenesis in the mouse embryo.
Topics: 1-Naphthylamine; Animals; Carrier Proteins; Cell Division; Cell Movement; Female; Fetal Heart; Fluoxetine; Immunohistochemistry; In Vitro Techniques; Mice; Mice, Inbred ICR; Nialamide; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Signal Transduction | 1993 |
Effects of three monoamine uptake inhibitors on behavior maintained by cocaine or food presentation in rhesus monkeys.
Topics: 1-Naphthylamine; Animals; Appetitive Behavior; Behavior, Animal; Cocaine; Dose-Response Relationship, Drug; Fluoxetine; Macaca mulatta; Mazindol; Motivation; Reinforcement Schedule; Selective Serotonin Reuptake Inhibitors; Self Administration; Sertraline | 1993 |
Effect of fluoxetine, norfluoxetine, sertraline and desmethyl sertraline on human CYP3A catalyzed 1'-hydroxy midazolam formation in vitro.
Topics: 1-Naphthylamine; Catalysis; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Microsomes, Liver; Midazolam; Mixed Function Oxygenases; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Female sexual side effects associated with selective serotonin reuptake inhibitors: a descriptive clinical study of 33 patients.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Female; Fluoxetine; Humans; Libido; Middle Aged; Orgasm; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 1995 |
Severe hyponatraemia associated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Depressive Disorder; Female; Fluoxetine; Humans; Hyponatremia; Referral and Consultation; Selective Serotonin Reuptake Inhibitors; Sertraline | 1995 |
Pharmacokinetics of the newer antidepressants.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Desipramine; Fluoxetine; Humans; Isoenzymes; Liver; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Base Sequence; Blotting, Northern; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; Imipramine; In Situ Hybridization; Male; Molecular Sequence Data; Nerve Growth Factors; Nerve Tissue Proteins; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, trkB; Receptors, Nerve Growth Factor; RNA, Messenger; Rolipram; Sertraline; Time Factors; Tranylcypromine | 1996 |
Drug-drug interactions.
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Desipramine; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Mixed Function Oxygenases; Paroxetine; Research Design; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Fluoxetine associated paresthesias and alopecia in a woman who tolerated sertraline.
Topics: 1-Naphthylamine; Adult; Alopecia; Depressive Disorder; Female; Fluoxetine; Humans; Paresthesia; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Affective Disorders, Psychotic; Aged; Ambulatory Care; Clozapine; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Middle Aged; Paroxetine; Schizophrenia; Selective Serotonin Reuptake Inhibitors; Sertraline; Stimulation, Chemical | 1996 |
Will pindolol augment the response to a serotonin reuptake inhibitor in obsessive-compulsive disorder?
Topics: 1-Naphthylamine; Adrenergic beta-Antagonists; Adult; Antidepressive Agents; Clomipramine; Drug Synergism; Female; Fluoxetine; Humans; Male; Middle Aged; Obsessive-Compulsive Disorder; Pindolol; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Differential potentiation of L-tryptophan-induced head-twitch response in mice by cocaine and sertraline.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Cocaine; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Head Movements; Male; Mice; Mice, Inbred ICR; Norepinephrine; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline; Tryptophan | 1996 |
Selective serotonin reuptake inhibitors (SSRIs) in the treatment of elderly depressed patients: a qualitative analysis of the literature on their efficacy and side-effects.
Topics: 1-Naphthylamine; Aged; Anorexia; Antidepressive Agents; Depressive Disorder; Diarrhea; Fluoxetine; Fluvoxamine; Humans; Meta-Analysis as Topic; Nausea; Paroxetine; Patient Dropouts; Selective Serotonin Reuptake Inhibitors; Sertraline; Single-Blind Method | 1996 |
[Reports of suspected side effects of selective serotonin reuptake inhibitors in Belgium and The Netherlands].
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Belgium; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Netherlands; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
The disposition of fluoxetine but not sertraline is altered in poor metabolizers of debrisoquin.
Topics: 1-Naphthylamine; Adolescent; Adrenergic Agents; Adult; Cytochrome P-450 CYP2D6; Debrisoquin; Fluoxetine; Humans; Male; Methylation; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Effects of antidepressants on the cytochrome P450 system.
Topics: 1-Naphthylamine; Antidepressive Agents; Cytochrome P-450 Enzyme System; Fluoxetine; Fluvoxamine; Humans; Medical Records; Paroxetine; Research Design; Sertraline | 1996 |
The stimulatory and inhibitory components of cocaine's actions on the 5-HTP-induced 5-HT2A receptor response.
Topics: 1-Naphthylamine; 5-Hydroxytryptophan; Animals; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Head Movements; Male; Mice; Mice, Inbred ICR; Norepinephrine; Piperazines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal.
Topics: 1-Naphthylamine; Adult; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Product Surveillance, Postmarketing; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome | 1996 |
A comparison of treatment of paraphilias with three serotonin reuptake inhibitors: a retrospective study.
Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Fluoxetine; Fluvoxamine; Humans; Libido; Male; Middle Aged; Paraphilic Disorders; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Inability to cry during SRI treatment.
Topics: 1-Naphthylamine; Adult; Crying; Depressive Disorder; Emotions; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors | 1996 |
Dexamethasone augmentation in treatment-resistant depression.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents, Second-Generation; Depressive Disorder; Dexamethasone; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Male; Middle Aged; Personality Inventory; Pituitary-Adrenal System; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Contribution of lysosomal trapping to the total tissue uptake of psychotropic drugs.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Drug Interactions; Fluoxetine; Imipramine; Lysosomes; Male; Monensin; Phospholipids; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Distribution | 1997 |
SSRI optimal dose remains at issue.
Topics: 1-Naphthylamine; Clinical Trials as Topic; Depressive Disorder; Drug Administration Schedule; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?
Topics: 1-Naphthylamine; Aggression; Animals; Anxiety; Binding, Competitive; Citalopram; Depression; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Rats; Rats, Wistar; Receptors, sigma; Selective Serotonin Reuptake Inhibitors; Sertraline; Vocalization, Animal | 1997 |
Behavioural effects of selective serotonin reuptake inhibitors following direct micro injection into the left red nucleus of the rat.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Chlorpromazine; Citalopram; Fluoxetine; Fluvoxamine; Guanidines; Haloperidol; Male; Microinjections; Motor Activity; Paroxetine; Piperidines; Posture; Rats; Rats, Sprague-Dawley; Receptors, sigma; Red Nucleus; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Drug interaction potential of fluoxetine, sertraline, and paroxetine in four state psychiatric hospital populations.
Topics: 1-Naphthylamine; Antidepressive Agents; Drug Interactions; Fluoxetine; Humans; Paroxetine; Sertraline | 1997 |
Comparative sexual side effects of bupropion, fluoxetine, paroxetine, and sertraline.
Topics: 1-Naphthylamine; Adult; Aged; Analysis of Variance; Antidepressive Agents, Second-Generation; Bupropion; Dopamine Uptake Inhibitors; Female; Fluoxetine; Humans; Male; Middle Aged; Orgasm; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Surveys and Questionnaires | 1997 |
An affinity-modulating site on neuronal monoamine transport proteins.
Topics: 1-Naphthylamine; Animals; Binding Sites; Biogenic Monoamines; Cerebral Cortex; Citalopram; Corpus Striatum; Female; Fluoxetine; In Vitro Techniques; Kinetics; Neurons; Piperazines; Rats; Receptors, Neurotransmitter; Sertraline; Stereoisomerism | 1997 |
Combining serotonin reuptake inhibitors and bupropion in partial responders to antidepressant monotherapy.
Topics: 1-Naphthylamine; Adult; Aged; Ambulatory Care; Anxiety Disorders; Bupropion; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Dysthymic Disorder; Epilepsy; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Panic Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1997 |
Psychiatrists' responses to failure of maintenance therapy with antidepressants.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Attitude of Health Personnel; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Fluoxetine; Humans; Lithium; Male; Nortriptyline; Recurrence; Sertraline; Treatment Failure | 1997 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
Open-label treatment of comorbid depression and attentional disorders with co-administration of serotonin reuptake inhibitors and psychostimulants in children, adolescents, and adults: a case series.
Topics: 1-Naphthylamine; Adolescent; Adult; Attention Deficit Disorder with Hyperactivity; Chemotherapy, Adjuvant; Child; Depressive Disorder; Female; Fluoxetine; Humans; Male; Methylphenidate; Psychotropic Drugs; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1996 |
Behavioral therapy in children and adolescents with obsessive-compulsive disorder: a pilot study.
Topics: 1-Naphthylamine; Adolescent; Behavior Therapy; Child; Combined Modality Therapy; Female; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Pilot Projects; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline | 1996 |
Erythromelalgia: response to serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Cyclohexanols; Erythromelalgia; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 1997 |
Concomitant use of selective serotonin reuptake inhibitors with other cytochrome P450 2D6 or 3A4 metabolized medications: how often does it really happen?
Topics: 1-Naphthylamine; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Fluoxetine; Humans; Liver; Metabolic Clearance Rate; Mixed Function Oxygenases; Paroxetine; Psychotropic Drugs; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 1997 |
Interactions between promazine and antidepressants at the level of cellular distribution.
Topics: 1-Naphthylamine; Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Antipsychotic Agents; Carbamazepine; Drug Interactions; Fluoxetine; Hydrogen-Ion Concentration; Imipramine; Lysosomes; Male; Promazine; Rats; Rats, Wistar; Sertraline | 1997 |
Sertraline for premenstrual dysphoric disorder.
Topics: 1-Naphthylamine; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Withdrawal reactions with selective serotonin re-uptake inhibitors as reported to the WHO system.
Topics: 1-Naphthylamine; Adverse Drug Reaction Reporting Systems; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; World Health Organization | 1997 |
Tricyclic antidepressant and selective serotonin reuptake inhibitors antidepressant selection and health care costs in the naturalistic setting: a multivariate analysis.
Topics: 1-Naphthylamine; Antidepressive Agents, Tricyclic; Depressive Disorder; Direct Service Costs; Drug Costs; Fee-for-Service Plans; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Insurance, Pharmaceutical Services; Male; Models, Econometric; Multivariate Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1998 |
Treatment-emergent changes in sexual function with selective serotonin reuptake inhibitors as measured with the Rush Sexual Inventory.
Topics: 1-Naphthylamine; Adult; Aged; Antidepressive Agents; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior | 1997 |
Selective serotonin reuptake inhibitor modulation of clozapine effects on cognition in schizophrenia.
Topics: 1-Naphthylamine; Adult; Antipsychotic Agents; Clozapine; Cognition; Depressive Disorder; Drug Synergism; Drug Therapy, Combination; Fluoxetine; Humans; Male; Neuropsychological Tests; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Bupropion treatment of serotonin reuptake antidepressant-associated sexual dysfunction.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Anxiety Disorders; Bupropion; Drug Therapy, Combination; Female; Fluoxetine; Humans; Libido; Male; Middle Aged; Mood Disorders; Pain Measurement; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Behavior; Sexual Dysfunctions, Psychological; Treatment Outcome | 1997 |
Treatment of premature ejaculation.
Topics: 1-Naphthylamine; Adult; Clomipramine; Ejaculation; Fluoxetine; Humans; Male; Patient Satisfaction; Randomized Controlled Trials as Topic; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunction, Physiological; Time Factors | 1998 |
[Choice of therapeutic tactics in treatment of endogenous depression by means of statusmetric expert system].
Topics: 1-Naphthylamine; Amitriptyline; Antidepressive Agents, Tricyclic; Depressive Disorder; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 1997 |
The SSRI antidepressants: exploring their "other" possible properties.
Topics: 1-Naphthylamine; Adult; Aged; Depressive Disorder; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Surveys and Questionnaires | 1998 |
Cocaine and selective monoamine uptake blockers (sertraline, nisoxetine, and GBR 12935) prevent the d-fenfluramine-induced head-twitch response in mice.
Topics: 1-Naphthylamine; Animals; Behavior, Animal; Cocaine; Fenfluramine; Fluoxetine; Male; Mice; Mice, Inbred ICR; Monoamine Oxidase Inhibitors; Piperazines; Receptors, Serotonin; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Black and white patients response to antidepressant treatment for major depression.
Topics: 1-Naphthylamine; Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Black People; Body Weight; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Length of Stay; Male; Middle Aged; Pharmacogenetics; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome; White People | 1998 |
Use of serotonin reuptake inhibitors by women of childbearing potential.
Topics: 1-Naphthylamine; Adult; Antidepressive Agents; Female; Fluoxetine; Humans; Pregnancy; Pregnancy Outcome; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
The oxidative metabolism of metoprolol in human liver microsomes: inhibition by the selective serotonin reuptake inhibitors.
Topics: 1-Naphthylamine; Adult; Anti-Arrhythmia Agents; Child; Citalopram; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Kinetics; Male; Methylation; Metoprolol; Microsomes, Liver; Oxidation-Reduction; Paroxetine; Quinidine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Dose-dependent influence of buspirone on the activities of selective serotonin reuptake inhibitors in the mouse forced swimming test.
Topics: Animals; Antidepressive Agents; Buspirone; Citalopram; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Exercise Test; Fluoxetine; Fluvoxamine; Male; Mice; Motor Activity; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 1998 |
Rapid response of emotional incontinence to selective serotonin reuptake inhibitors.
Topics: Adult; Affective Symptoms; Aged; Brain Injuries; Cerebrovascular Disorders; Crying; Fluoxetine; Humans; Laughter; Male; Middle Aged; Multiple Sclerosis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Discontinuation of antidepressant therapy: emerging complications and their relevance.
Topics: Antidepressive Agents; Depressive Disorder; Fluoxetine; Humans; Paroxetine; Placebos; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome; Syndrome; Terminology as Topic | 1998 |
Visual hallucinations associated with fluoxetine and sertraline.
Topics: Adult; Antidepressive Agents; Depression; Fluoxetine; Hallucinations; Humans; Male; Sertraline | 1998 |
Using secondary binding properties to select a not so selective serotonin reuptake inhibitor.
Topics: Adolescent; Adult; Child; Citalopram; Cytochrome P-450 Enzyme System; Drug Prescriptions; Fluoxetine; Fluvoxamine; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1998 |
Trends in the use of selective serotonin reuptake inhibitors in nine Department of Veterans Affairs outpatient facilities.
Topics: Depressive Disorder; Drug Costs; Drug Prescriptions; Fluoxetine; Hospitals, Veterans; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Fluoxetine and sertraline dosages in major depression.
Topics: Depressive Disorder; Dose-Response Relationship, Drug; Fluoxetine; Humans; Retrospective Studies; Sertraline | 1999 |
SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis.
Topics: Adult; Databases, Factual; Depressive Disorder; Drug Utilization; Episode of Care; Female; Fluoxetine; Humans; Logistic Models; Male; Multivariate Analysis; Paroxetine; Psychotherapy; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1999 |
The potentiating effect of sertraline and fluoxetine on amphetamine-induced locomotor activity is not mediated by serotonin.
Topics: Amphetamine; Analysis of Variance; Animals; Brain; Central Nervous System Stimulants; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Locomotion; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline | 1999 |
The role of lysosomes in the cellular distribution of thioridazine and potential drug interactions.
Topics: Amitriptyline; Ammonium Chloride; Animals; Antidepressive Agents; Chromatography, High Pressure Liquid; Drug Interactions; Fluoxetine; Imipramine; In Vitro Techniques; Lysosomes; Male; Monensin; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Thioridazine | 1999 |
The influence of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics of thioridazine and its metabolites: in vivo and in vitro studies.
Topics: Animals; Antipsychotic Agents; Brain; Chromatography, High Pressure Liquid; Fluoxetine; Fluvoxamine; Male; Microsomes, Liver; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Thioridazine | 1999 |
Effect of some antidepressants on glycaemia and insulin levels of normoglycaemic and alloxan-induced hyperglycaemic mice.
Topics: Alloxan; Animals; Antidepressive Agents; Blood Glucose; Female; Fluoxetine; Hyperglycemia; Insulin; Male; Mice; Nortriptyline; Sertraline | 1999 |
Excretion of paroxetine into breast milk.
Topics: Adult; Breast Feeding; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Fluvoxamine; Humans; Lactation; Milk, Human; Panic Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Triglycerides | 1999 |
Modeling the pharmacoeconomic cost of three selective serotonin reuptake inhibitors.
Topics: Dose-Response Relationship, Drug; Fluoxetine; Follow-Up Studies; Humans; Mental Disorders; Mental Health Services; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Economic appraisal of citalopram in the management of single-episode depression.
Topics: Adult; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cohort Studies; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Health Maintenance Organizations; Humans; Male; Middle Aged; Paroxetine; Patient Care Team; Retrospective Studies; Sertraline | 1999 |
Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.
Topics: Adolescent; Adult; Aged; Antidepressive Agents; Antidepressive Agents, Second-Generation; Cost of Illness; Cost-Benefit Analysis; Depressive Disorder; Female; Fluoxetine; Follow-Up Studies; Health Care Costs; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 1999 |
The behavioral effects of sertraline, fluoxetine, and paroxetine differ on the differential-reinforcement-of-low-rate 72-second operant schedule in the rat.
Topics: Animals; Conditioning, Operant; Differential Threshold; Fluoxetine; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Reinforcement, Psychology; Selective Serotonin Reuptake Inhibitors; Sertraline | 1999 |
Treatment of pathological affect: variability of response for laughter and crying.
Topics: Aged; Crying; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Laughter; Male; Middle Aged; Mood Disorders; Motor Neuron Disease; Sertraline | 2000 |
Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry.
Topics: Animals; Appetite Depressants; Body Weight; Cyclobutanes; Dexfenfluramine; Eating; Fluoxetine; Immunohistochemistry; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prefrontal Cortex; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Sertraline | 2000 |
Spectrophotometric determination of fluoxetine and sertraline using chloranil, 2, 3 dichloro-5, 6 dicyano benzoquinone and iodine.
Topics: Antidepressive Agents; Benzoquinones; Chemistry, Pharmaceutical; Chloranil; Fluoxetine; Iodine; Sertraline; Spectrum Analysis | 1999 |
Effects of antidepressants in adrenergic neurotransmission of human vas deferens.
Topics: Amitriptyline; Antidepressive Agents; Calcium; Calcium Channel Blockers; Culture Techniques; Dose-Response Relationship, Drug; Fluoxetine; Humans; Male; Muscle Contraction; Nifedipine; Receptors, Adrenergic; Sertraline; Synaptic Transmission; Vas Deferens | 2000 |
Naturalistic study of the weight effects of amitriptyline, fluoxetine, and sertraline in an outpatient medical setting.
Topics: Adult; Aged; Aged, 80 and over; Ambulatory Care; Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Female; Fluoxetine; Humans; Male; Middle Aged; Retrospective Studies; Sertraline; Weight Gain | 2000 |
Inhibitory effect of serotonergic drugs on contractile response of the rat vas deferens to electrical nerve stimulation: in vivo study.
Topics: Animals; Clomipramine; Electric Stimulation; Fluoxetine; Male; Muscle Contraction; Muscle, Smooth; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Vas Deferens | 2000 |
Dose of selective serotonin uptake inhibitors across pregnancy: clinical implications.
Topics: Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluoxetine; Humans; Infant, Newborn; Paroxetine; Pregnancy; Pregnancy Complications; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2000 |
Newer antidepressants: a comparison of tolerability in general practice.
Topics: Adult; Aged; Antidepressive Agents; Cohort Studies; Cyclohexanols; Depressive Disorder; Family Practice; Female; Fluoxetine; Humans; Male; Middle Aged; Moclobemide; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1999 |
Simultaneous determination of human plasma levels of four selective serotonin reuptake inhibitors by high-performance liquid chromatography.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Chromatography, High Pressure Liquid; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluorometry; Fluoxetine; Fluvoxamine; Humans; Linear Models; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline | 2000 |
Antidepressant-induced regulation of 5-HT(1b) mRNA in rat dorsal raphe nucleus reverses rapidly after drug discontinuation.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Autoreceptors; Fluoxetine; Gene Expression; In Situ Hybridization; Male; Nortriptyline; Paroxetine; Raphe Nuclei; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT1B; Receptors, Serotonin; RNA, Messenger; Sertraline | 2000 |
Terfenadine-antidepressant interactions: an in vitro inhibition study using human liver microsomes.
Topics: Alkylation; Antidepressive Agents, Second-Generation; Biotransformation; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Fluoxetine; Histamine H1 Antagonists; Humans; Hydroxylation; Microsomes, Liver; Mixed Function Oxygenases; Piperazines; Sertraline; Terfenadine; Triazoles | 1998 |
CYP2B6 mediates the in vitro hydroxylation of bupropion: potential drug interactions with other antidepressants.
Topics: Antibodies; Antidepressive Agents, Second-Generation; Aryl Hydrocarbon Hydroxylases; Biotransformation; Bupropion; Chromatography, High Pressure Liquid; Cytochrome P-450 CYP2B6; Cytochrome P-450 Enzyme System; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Fluvoxamine; Humans; Hydroxylation; Isoenzymes; Kinetics; Microsomes, Liver; Oxidoreductases, N-Demethylating; Paroxetine; Piperazines; Sertraline; Triazoles | 2000 |
Determination of four selective serotonin reuptake inhibitors by capillary isotachophoresis.
Topics: Citalopram; Electrophoresis, Capillary; Fluoxetine; Fluvoxamine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
The effects of sertraline and fluoxetine on anxiety in the elevated plus-maze test in mice.
Topics: Animals; Anxiety; Dose-Response Relationship, Drug; Fluoxetine; Male; Maze Learning; Mice; Selective Serotonin Reuptake Inhibitors; Sertraline | 2000 |
Do antidepressants affect motivation in conditioned place preference?
Topics: Adrenergic Uptake Inhibitors; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Cocaine; Conditioning, Psychological; Cyclobutanes; Cyclohexanols; Dose-Response Relationship, Drug; Fluoxetine; Male; Motivation; Norepinephrine; Paroxetine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2000 |
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain | 2001 |
Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release.
Topics: 5-Hydroxytryptophan; Animals; Antidepressive Agents; Cell Division; Desipramine; Dopamine Uptake Inhibitors; Fenclonine; Fluoxetine; Lymphocyte Activation; Lymphocytes; Male; Mitogens; Neurons; p-Chloroamphetamine; Piperazines; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Sertraline | 2000 |
Inhibition of phenytoin hydroxylation in human liver microsomes by several selective serotonin re-uptake inhibitors.
Topics: Aged; Anticonvulsants; Aryl Hydrocarbon Hydroxylases; Child, Preschool; Cytochrome P-450 CYP2C9; Cytochrome P-450 Enzyme System; Drug Interactions; Female; Fluoxetine; Humans; Hydroxylation; Male; Microsomes, Liver; Middle Aged; Paroxetine; Phenytoin; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases | 2001 |
Effects of selective serotonin reuptake inhibitors on sexual function.
Topics: Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Sexual Dysfunctions, Psychological | 2001 |
Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expenditures.
Topics: Adult; Antidepressive Agents; Cross-Sectional Studies; Drug Costs; Fluoxetine; Fluvoxamine; Forecasting; Humans; Insurance Claim Reporting; Insurance, Pharmaceutical Services; Middle Aged; Models, Theoretical; Ontario; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Prefrontal changes and treatment response prediction in depression.
Topics: Adult; Antidepressive Agents; Cyclohexanols; Depression; Depressive Disorder, Major; Electroencephalography; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Prefrontal Cortex; Sertraline; Venlafaxine Hydrochloride | 2001 |
Economic evaluation of major selective serotonin-reuptake inhibitors in a managed care population.
Topics: Adolescent; Adult; Depressive Disorder; Drug Costs; Episode of Care; Fluoxetine; Humans; Managed Care Programs; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2001 |
The effect of selective serotonin reuptake inhibitors (SSRIs) on the pharmacokinetics and metabolism of perazine in the rat.
Topics: Animals; Brain; Dopamine Antagonists; Drug Interactions; Fluoxetine; Fluvoxamine; Infusions, Parenteral; Male; Perazine; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Comparison of peripheral inhibitory effects of clomipramine with selective serotonin re-uptake inhibitors on contraction of vas deferens: in vitro and in vivo studies.
Topics: Adult; Antidepressive Agents, Tricyclic; Clomipramine; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Humans; Male; Muscle Contraction; Muscle, Smooth; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Vas Deferens | 2001 |
[The transfer of selective serotonin reuptake inhibitors to human milk].
Topics: Antidepressive Agents; Breast Feeding; Citalopram; Depression, Postpartum; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Milk, Human; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Serotonin reuptake inhibitor antidepressants and pregnancy: many unanswered questions.
Topics: Abnormalities, Drug-Induced; Antidepressive Agents, Second-Generation; Child; Child, Preschool; Clinical Trials as Topic; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Infant; Infant, Newborn; Paroxetine; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 1999 |
Intracellular distribution of psychotropic drugs in the grey and white matter of the brain: the role of lysosomal trapping.
Topics: Amitriptyline; Animals; Astrocytes; Brain; Cells, Cultured; Fluoxetine; In Vitro Techniques; Lysosomes; Neurons; Perazine; Promazine; Psychotropic Drugs; Rats; Rats, Wistar; Sertraline; Thioridazine | 2001 |
The effect of selective serotonin reuptake inhibitor treatment of panic disorder on emergency room and laboratory resource utilization.
Topics: Adolescent; Adult; Cohort Studies; Cost Savings; Drug Costs; Emergency Service, Hospital; Female; Fluoxetine; Health Care Costs; Humans; Insurance Claim Review; Laboratories; Laboratories, Hospital; Male; Managed Care Programs; Middle Aged; Panic Disorder; Paroxetine; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2001 |
Selections from current literature. Treatments for premenstrual dysphoric disorder.
Topics: Affective Symptoms; Antidepressive Agents; Calcium; Female; Fluoxetine; Humans; Luteal Phase; Phytotherapy; Plant Preparations; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Vitex | 2001 |
Effects of standardized extracts of St. John's wort on the single-unit activity of serotonergic dorsal Raphe neurons in awake cats: comparisons with fluoxetine and sertraline.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Cats; Electrophysiology; Fluoxetine; Hypericum; Male; Membrane Potentials; Neurons; Piperazines; Plant Extracts; Pyridines; Raphe Nuclei; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sertraline | 2001 |
Extending indications for long-term pharmacotherapy: opportunities and challenges.
Topics: Bulimia; Chronic Disease; Fluoxetine; Humans; Long-Term Care; Obsessive-Compulsive Disorder; Sertraline | 2002 |
Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635.
Topics: Aminopyridines; Animals; Antidepressive Agents, Second-Generation; Anxiety; Behavior, Animal; Fluoxetine; Grooming; Indoles; Interpersonal Relations; Male; Motor Activity; Piperazines; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin Antagonists; Sertraline | 2001 |
Duration of therapy and health care costs of fluoxetine, paroxetine, and sertraline in 6 health plans.
Topics: Adolescent; Adult; Depressive Disorder; Drug Administration Schedule; Drug Costs; Female; Fluoxetine; Health Care Costs; Health Maintenance Organizations; Humans; Insurance, Pharmaceutical Services; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2002 |
Davidson Trauma Scale (DTS): normative scores in the general population and effect sizes in placebo-controlled SSRI trials.
Topics: Adult; Clinical Trials as Topic; Effect Modifier, Epidemiologic; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Psychometrics; Reference Values; Sampling Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Treatment Outcome | 2002 |
Up-regulation of tryptophan hydroxylase expression and serotonin synthesis by sertraline.
Topics: Animals; Cyclic AMP-Dependent Protein Kinases; Fluoxetine; Gene Expression; Male; Models, Animal; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Tryptophan Hydroxylase; Up-Regulation | 2002 |
Is one selective serotonin reuptake inhibitor better than another?
Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Is one selective serotonin reuptake inhibitor better than another?
Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Is one selective serotonin reuptake inhibitor better than another?
Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Is one selective serotonin reuptake inhibitor better than another?
Topics: Antidepressive Agents; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Hyponatremia associated with sertraline and fluoxetine: a case report.
Topics: Aged; Aged, 80 and over; Antidepressive Agents; Antidepressive Agents, Second-Generation; Depressive Disorder; Fluoxetine; Humans; Hyponatremia; Inappropriate ADH Syndrome; Male; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2002 |
Are paroxetine, fluoxetine, and sertraline equally effective for depression?
Topics: Adult; Depressive Disorder; Evidence-Based Medicine; Fluoxetine; Humans; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activity.
Topics: Acetylcholinesterase; Adolescent; Adult; Amitriptyline; Antidepressive Agents; Butyrylcholinesterase; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Erythrocyte Membrane; Female; Fluoxetine; Humans; Kinetics; Male; Middle Aged; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
SSRIs: take your pick.
Topics: Depression; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Beyond premenstrual syndrome.
Topics: Adult; Antidepressive Agents; Drug Approval; Female; Fluoxetine; Humans; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; United States Food and Drug Administration | 2002 |
Variations in antidepressant prescribing practice: clinical need or market influences?
Topics: Antidepressive Agents; Community Psychiatry; Drug Utilization Review; Fluoxetine; Humans; Marketing; Paroxetine; Physicians, Family; Practice Patterns, Physicians'; Sertraline; Surveys and Questionnaires | 2002 |
Side effects after phototherapy implementation in addition to fluoxetine or sertraline treatment: a report of two cases.
Topics: Adult; Drug Synergism; Female; Fluoxetine; Humans; Male; Middle Aged; Phototherapy; Seasonal Affective Disorder; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 2002 |
Strategies to decrease costs of prescribing selective serotonin reuptake inhibitors at a VA Medical Center.
Topics: Citalopram; Clinical Pharmacy Information Systems; Cost Control; Cost Savings; Drug Administration Schedule; Drug Costs; Drug Utilization; Fluoxetine; Fluvoxamine; Hospital Costs; Hospitals, Veterans; Humans; Mental Disorders; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2003 |
Selective serotonin reuptake inhibitor usage patterns as risk factors for hospitalization.
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder; Drug Utilization Review; Fluoxetine; Health Maintenance Organizations; Hospitalization; Humans; Medical Audit; Midwestern United States; Paroxetine; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline | 2002 |
Is left stroke a risk-factor for selective serotonin reuptake inhibitor antidepressant treatment resistance?
Topics: Administration, Oral; Aged; Cognition; Depressive Disorder; Drug Resistance; Female; Fluoxetine; Functional Laterality; Humans; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; Psychometrics; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Stroke | 2003 |
Burning mouth syndrome as a side effect of SSRIs.
Topics: Burning Mouth Syndrome; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Placental passage of antidepressant medications.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fetal Blood; Fluoxetine; Humans; Maternal-Fetal Exchange; Paroxetine; Placenta; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Sertraline | 2003 |
The effect of combined administration of ethanol and sertraline, fluoxetine and citalopram on rabbit EEG.
Topics: Analysis of Variance; Animals; Brain; Citalopram; Electroencephalography; Ethanol; Female; Fluoxetine; Male; Rabbits; Sertraline | 2003 |
Evaluation of the anti-inflammatory and anti-nociceptive effects of different antidepressants in the rat.
Topics: Amitriptyline; Analysis of Variance; Animals; Antidepressive Agents; Carrageenan; Clomipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Electroshock; Fluoxetine; Imipramine; Inflammation; Male; Pain; Pain Measurement; Rats; Rats, Sprague-Dawley; Sertraline; Trazodone | 2003 |
Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.
Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Depressive Disorder, Major; Double-Blind Method; Female; Fluoxetine; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2003 |
Psychopharmacological treatment of major depressive disorder in children and adolescents.
Topics: Adolescent; Antidepressive Agents; Child; Depressive Disorder, Major; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2003 |
Selective serotonin reuptake inhibitors in pilot fatalities of civil aviation accidents, 1990-2001.
Topics: Accidents, Aviation; Aerospace Medicine; Certification; Citalopram; Databases as Topic; Environmental Monitoring; Fluoxetine; Humans; Paroxetine; Postmortem Changes; Selective Serotonin Reuptake Inhibitors; Sertraline; Survival Rate; United States | 2003 |
Fluoxetine, but not sertraline or citalopram, potentiates the locomotor stimulant effect of cocaine: possible pharmacokinetic effects.
Topics: 5,7-Dihydroxytryptamine; Animals; Behavior, Animal; Biogenic Monoamines; Brain; Brain Chemistry; Chromatography, High Pressure Liquid; Citalopram; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Synergism; Fluoxetine; Male; Motor Activity; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin Agents; Sertraline; Tissue Distribution | 2004 |
In vivo rat model to measure hypogastric nerve stimulation-induced seminal vesicle and vasal pressure responses simultaneously.
Topics: Animals; Clomipramine; Electric Stimulation; Fluoxetine; Hypogastric Plexus; In Vitro Techniques; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Seminal Vesicles; Serotonin; Sertraline; Vas Deferens | 2004 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
Topics: Adult; Benzylamines; Carbon Radioisotopes; Carrier Proteins; Citalopram; Corpus Striatum; Cyclohexanols; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Tomography, Emission-Computed; Venlafaxine Hydrochloride | 2004 |
Norepinephrine-deficient mice lack responses to antidepressant drugs, including selective serotonin reuptake inhibitors.
Topics: Animals; Antidepressive Agents; Citalopram; Depression; Desipramine; Dopamine beta-Hydroxylase; Droxidopa; Fluoxetine; Gene Deletion; Mice; Morpholines; Norepinephrine; Paroxetine; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Tail | 2004 |
Fluoxetine and sertraline stimulate gastric acid secretion via a vagal pathway in anaesthetised rats.
Topics: Anesthesia; Animals; Dose-Response Relationship, Drug; Female; Fluoxetine; Gastric Acid; Male; Neural Pathways; Rats; Rats, Sprague-Dawley; Sertraline; Vagus Nerve | 2004 |
Changes in energy after switching from daily citalopram, paroxetine, or sertraline to once-weekly fluoxetine.
Topics: Citalopram; Depressive Disorder; Drug Administration Schedule; Fatigue; Fluoxetine; Humans; Paroxetine; Quality of Life; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Neonatal complications after intrauterine exposure to SSRI antidepressants.
Topics: Antidepressive Agents; Citalopram; Depression; Female; Fluoxetine; Fluvoxamine; Follow-Up Studies; France; Humans; Infant, Newborn; Neonatal Abstinence Syndrome; Paroxetine; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Third; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline | 2004 |
Evaluation of cognitive function of fluoxetine, sertraline and tianeptine in isolation and chronic unpredictable mild stress-induced depressive Wistar rats.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cognition Disorders; Depression; Female; Fluoxetine; Male; Rats; Rats, Wistar; Sertraline; Stress, Physiological; Thiazepines | 2003 |
Drugs vs. talk therapy: 3,079 readers rate their care for depression and anxiety.
Topics: Antidepressive Agents; Anxiety; Anxiety Disorders; Bupropion; Citalopram; Cyclohexanols; Depression; Drug Therapy; Fluoxetine; Humans; Paroxetine; Patient Satisfaction; Primary Health Care; Psychiatry; Psychology; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Social Work | 2004 |
Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia.
Topics: Animals; Citalopram; Cladocera; Ecosystem; Female; Fluoxetine; Fluvoxamine; Lethal Dose 50; Male; No-Observed-Adverse-Effect Level; Paroxetine; Reproduction; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests, Acute; Toxicity Tests, Chronic; Water Pollutants, Chemical | 2004 |
In vivo identification and characterization of binding sites for selective serotonin reuptake inhibitors in mouse brain.
Topics: Analysis of Variance; Animals; Area Under Curve; Binding Sites; Brain; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Fluoxetine; Fluvoxamine; Male; Mice; Mice, Inbred ICR; Paroxetine; Radioligand Assay; Receptors, Serotonin; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Tritium | 2004 |
Fluvoxamine: new indication. No progress in obsessive-compulsive disorder.
Topics: Adolescent; Adult; Child; Drug Approval; Fluoxetine; France; Humans; Obsessive-Compulsive Disorder; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2004 |
Itch and skin rash from chocolate during fluoxetine and sertraline treatment: case report.
Topics: Cacao; Depressive Disorder; Exanthema; Fluoxetine; Humans; Male; Middle Aged; Pruritus; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline | 2004 |
Relationship between brain serotonin transporter binding, plasma concentration and behavioural effect of selective serotonin reuptake inhibitors.
Topics: Animals; Behavior, Animal; Binding Sites; Brain; Fluoxetine; Fluvoxamine; Membrane Glycoproteins; Membrane Transport Proteins; Mice; Mice, Inbred ICR; Motor Activity; Nerve Tissue Proteins; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2005 |
Determination of select antidepressants in fish from an effluent-dominated stream.
Topics: Animals; Antidepressive Agents; Brain; Fishes; Fluoxetine; Liver; Muscles; Rivers; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; Water Pollutants, Chemical | 2005 |
Rapid screening of selective serotonin re-uptake inhibitors in urine samples using solid-phase microextraction gas chromatography-mass spectrometry.
Topics: Antidepressive Agents, Second-Generation; Citalopram; Cyclohexanols; Fluoxetine; Fluvoxamine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Mirtazapine; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Solid Phase Microextraction; Venlafaxine Hydrochloride | 2005 |
Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors.
Topics: Environmental Exposure; European Union; Fluoxetine; Fluvoxamine; Forecasting; Humans; Models, Theoretical; Selective Serotonin Reuptake Inhibitors; Sertraline; United States; Water Pollutants, Chemical | 2005 |
Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice.
Topics: Animals; Anti-Dyskinesia Agents; Catalepsy; Disease Models, Animal; Female; Fluoxetine; Haloperidol; Male; Mice; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Time Factors | 2005 |
Development of a solid phase extraction for 13 'new' generation antidepressants and their active metabolites for gas chromatographic-mass spectrometric analysis.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Desvenlafaxine Succinate; Fluoxetine; Gas Chromatography-Mass Spectrometry; Humans; Mianserin; Microchemistry; Mirtazapine; Piperazines; Reproducibility of Results; Sertraline | 2005 |
The spermicidal and antitrichomonas activities of SSRI antidepressants.
Topics: Animals; Antidepressive Agents; Antitrichomonal Agents; Drug Evaluation, Preclinical; Fluoxetine; Fluvoxamine; Humans; In Vitro Techniques; Male; Molecular Structure; Selective Serotonin Reuptake Inhibitors; Sertraline; Spermatocidal Agents; Spermatozoa; Structure-Activity Relationship; Trichomonas vaginalis | 2006 |
Determining the duration of antidepressant treatment: application of signal detection methodology and the need for duration adaptive designs (DAD).
Topics: Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Follow-Up Studies; Humans; Nortriptyline; Personality Assessment; Probability; Psychometrics; Randomized Controlled Trials as Topic; Retrospective Studies; Sertraline; Signal Detection, Psychological | 2006 |
Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromsø, Norway.
Topics: Calibration; Chemical Fractionation; Chromatography, High Pressure Liquid; Citalopram; Fluoxetine; Fluvoxamine; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sewage; Water Pollutants, Chemical | 2006 |
I have read about a new study that showed antidepressants can increase the risk of abdominal bleeding. I'm currently taking Prozac, and my husband takes Zoloft. Should we worry?
Topics: Antidepressive Agents; Drug Interactions; Female; Fluoxetine; Gastrointestinal Hemorrhage; Humans; Male; Paroxetine; Polypharmacy; Sertraline | 2006 |
Persistent sexual side effects after SSRI discontinuation.
Topics: Adult; Androgens; Anxiety; Bupropion; Cabergoline; Citalopram; Depressive Disorder; Dopamine Agonists; Dopamine Uptake Inhibitors; Ergolines; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Piperazines; Plants, Medicinal; Purines; Selective Serotonin Reuptake Inhibitors; Selegiline; Sertraline; Sexual Dysfunctions, Psychological; Sildenafil Citrate; Sleep Initiation and Maintenance Disorders; Sulfones; Testosterone; Time Factors; Treatment Outcome; Vasodilator Agents | 2006 |
Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment.
Topics: Animals; Antidepressive Agents; Cyclohexanols; Electroconvulsive Therapy; Expressed Sequence Tags; Fluoxetine; Frontal Lobe; Imipramine; Male; Neuropeptides; Neuroserpin; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serpins; Sertraline; Venlafaxine Hydrochloride | 2006 |
Antidepressant therapy and C-reactive protein levels.
Topics: Adult; Aged; C-Reactive Protein; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2006 |
Toxicity and hazard of selective serotonin reuptake inhibitor antidepressants fluoxetine, fluvoxamine, and sertraline to algae.
Topics: Biomass; Chlorella vulgaris; Dose-Response Relationship, Drug; Eukaryota; Fluoxetine; Fluvoxamine; Phytoplankton; Risk Assessment; Scenedesmus; Selective Serotonin Reuptake Inhibitors; Sertraline; Species Specificity; Structure-Activity Relationship; Time Factors; Water Pollutants, Chemical | 2007 |
Monoamine transporter gene polymorphisms and antidepressant response in koreans with late-life depression.
Topics: Adult; Aged; Antidepressive Agents; Asian People; Depressive Disorder, Major; Female; Fluoxetine; Humans; Korea; Male; Middle Aged; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Nortriptyline; Polymorphism, Genetic; Promoter Regions, Genetic; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2006 |
Analgesic effects of serotonergic, noradrenergic or dual reuptake inhibitors in the carrageenan test in rats: evidence for synergism between serotonergic and noradrenergic reuptake inhibition.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Brain Chemistry; Carrageenan; Cyclohexanols; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Duloxetine Hydrochloride; Edema; Fluoxetine; Hot Temperature; Hyperalgesia; Male; Norepinephrine; Paroxetine; Pressure; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Thiophenes; Venlafaxine Hydrochloride | 2006 |
Cost-utility of selective serotonin reuptake inhibitors for depression in primary care in Catalonia.
Topics: Adolescent; Adult; Aged; Catchment Area, Health; Citalopram; Cost-Benefit Analysis; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Fluoxetine; Health Expenditures; Humans; Male; Middle Aged; Paroxetine; Primary Health Care; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Spain | 2006 |
Effects of antidepressant treatment on neural correlates of emotional and neutral declarative verbal memory in depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Emotions; Female; Fluoxetine; Frontal Lobe; Gyrus Cinguli; Humans; Male; Mental Recall; Middle Aged; Paired-Associate Learning; Personality Inventory; Positron-Emission Tomography; Semantics; Sertraline; Venlafaxine Hydrochloride; Wechsler Scales | 2007 |
The potential for clinically significant drug-drug interactions involving the CYP 2D6 system: effects with fluoxetine and paroxetine versus sertraline.
Topics: Cross-Sectional Studies; Cytochrome P-450 CYP2D6 Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Medication Errors; Middle Aged; Paroxetine; Retrospective Studies; Risk; Selective Serotonin Reuptake Inhibitors; Sertraline; Veterans | 2007 |
Sertraline and fluoxetine: safe treatments for children and adolescents with epilepsy and depression.
Topics: Adolescent; Child; Child, Preschool; Depression; Epilepsy; Female; Fluoxetine; Humans; Male; Neurologic Examination; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychotic Disorders; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Enhanced reactivity of 5-HT1A receptors in the rat dorsal periaqueductal gray matter after chronic treatment with fluoxetine and sertraline: evidence from the elevated T-maze.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Behavior, Animal; Drug Interactions; Fluoxetine; Male; Maze Learning; Periaqueductal Gray; Rats; Rats, Wistar; Reaction Time; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Sertraline | 2007 |
Trichotillomania and co-morbid psychiatric disorders in a 10-year-old boy.
Topics: Attention Deficit Disorder with Hyperactivity; Child; Clonidine; Comorbidity; Drug Therapy, Combination; Fluoxetine; Humans; Male; Mental Status Schedule; Obsessive-Compulsive Disorder; Referral and Consultation; Sertraline; Tourette Syndrome; Trichotillomania | 2007 |
Antidepressants in children and adolescents--changes in utilisation after safety warnings.
Topics: Adolescent; Adult; Antidepressive Agents, Second-Generation; Australia; Child; Databases, Factual; Drug Labeling; Drug Utilization; Drug Utilization Review; Fluoxetine; Government Agencies; Humans; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2007 |
Ecchymoses as an adverse effect of fluoxetine treatment.
Topics: Adult; Antidepressive Agents, Second-Generation; Depressive Disorder, Major; Ecchymosis; Female; Fluoxetine; Follow-Up Studies; Humans; Sertraline | 2007 |
An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials.
Topics: Antidepressive Agents; Anxiety Disorders; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Kava; Mianserin; Mirtazapine; Paroxetine; Psychometrics; Sertraline; Stress Disorders, Post-Traumatic; Surveys and Questionnaires; Venlafaxine Hydrochloride | 2007 |
Use and tolerability of newer antipsychotics and antidepressants: a chart review in a paediatric setting.
Topics: Adolescent; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Child; Citalopram; Drug Utilization Review; Female; Fluoxetine; Humans; Hyperprolactinemia; Italy; Male; Medical Records; Mental Disorders; Olanzapine; Paroxetine; Practice Patterns, Physicians'; Retrospective Studies; Risperidone; Sertraline; Treatment Outcome | 2008 |
Use of Bayesian net benefit regression model to examine the impact of generic drug entry on the cost effectiveness of selective serotonin reuptake inhibitors in elderly depressed patients.
Topics: Aged; Aged, 80 and over; Algorithms; Bayes Theorem; Citalopram; Cost-Benefit Analysis; Depression; Drugs, Generic; Female; Fluoxetine; Humans; Male; Medicare; Models, Statistical; Paroxetine; Regression Analysis; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States | 2007 |
Addition of cognitive-behavioral therapy for nonresponders to medication for obsessive-compulsive disorder: a naturalistic study.
Topics: Adult; Citalopram; Clomipramine; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Demography; Drug Resistance; Female; Fluoxetine; Fluvoxamine; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Practice Guidelines as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2007 |
Zooplankton chitobiase activity as an endpoint of pharmaceutical effect.
Topics: Acetylglucosaminidase; Animals; Atorvastatin; Biological Assay; Daphnia; Dose-Response Relationship, Drug; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Environmental Monitoring; Fluoxetine; Heptanoic Acids; Lethal Dose 50; Lovastatin; Pyrroles; Sertraline; Water Pollutants, Chemical; Xenobiotics; Zooplankton | 2008 |
Sertraline and tic: case report.
Topics: Adult; Depressive Disorder, Major; Eyelids; Female; Fluoxetine; Humans; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline; Stereotyped Behavior; Tics | 2007 |
Geometric mean IELT and premature ejaculation: appropriate statistics to avoid overestimation of treatment efficacy.
Topics: Antidepressive Agents; Coitus; Data Interpretation, Statistical; Ejaculation; Fluoxetine; Fluvoxamine; Humans; Male; Mianserin; Mirtazapine; Models, Biological; Piperazines; Reaction Time; Research Design; Selective Serotonin Reuptake Inhibitors; Sensitivity and Specificity; Sertraline; Sexual Dysfunction, Physiological; Treatment Outcome; Triazoles | 2008 |
Clinical inquiries. What's the best drug treatment for premature ejaculation?
Topics: Anesthetics, Local; Antidepressive Agents; Clomipramine; Ejaculation; Fluoxetine; Humans; Lidocaine; Lidocaine, Prilocaine Drug Combination; Male; Paroxetine; Phosphodiesterase Inhibitors; Prilocaine; Sertraline; Sexual Dysfunction, Physiological; Sexual Dysfunctions, Psychological; Treatment Outcome | 2008 |
Cerebral metabolic effects of fluoxetine, fluvoxamine, paroxetine and sertraline in the conscious rat.
Topics: Animals; Brain; Brain Mapping; Carbon Isotopes; Deoxyglucose; Dose-Response Relationship, Drug; Fluoxetine; Male; Paroxetine; Radionuclide Imaging; Rats; Rats, Inbred F344; Selective Serotonin Reuptake Inhibitors; Sertraline; Wakefulness | 2008 |
Fatal intoxication with milnacipran.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents; Chromatography, High Pressure Liquid; Cyclopropanes; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Milnacipran; Nordazepam; Oxazepam; Phenothiazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide | 2008 |
Flat dose-response curves for efficacy: what do they mean to the clinician?
Topics: Attitude of Health Personnel; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluoxetine; Humans; Neurotransmitter Uptake Inhibitors; Paroxetine; Physicians; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; United States; United States Food and Drug Administration | 2008 |
[A place for SSRIs in the treatment of severely depressed children and adolescents].
Topics: Adolescent; Antidepressive Agents, Second-Generation; Child; Cyclohexanols; Depressive Disorder, Major; Fluoxetine; Humans; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Venlafaxine Hydrochloride | 2008 |
Comparing interventions for selective mutism: a pilot study.
Topics: Child; Combined Modality Therapy; Female; Fluoxetine; Follow-Up Studies; Humans; Male; Mutism; Personality Assessment; Phobic Disorders; Pilot Projects; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Social Environment; Speech Therapy | 2008 |
Recent NIMH clinical trials and implications for practice.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Behavior Therapy; Central Nervous System Stimulants; Child; Child Development Disorders, Pervasive; Child, Preschool; Cognitive Behavioral Therapy; Combined Modality Therapy; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Fluoxetine; Humans; Mental Disorders; Methylphenidate; Multicenter Studies as Topic; National Institute of Mental Health (U.S.); Obsessive-Compulsive Disorder; Psychotropic Drugs; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2008 |
Analysis of second-generation antidepressant drug, sertraline and its active metabolite, N-desmethyl sertraline in human plasma by a sensitive and selective liquid chromatography-tandem mass spectrometry method.
Topics: Antidepressive Agents, Second-Generation; Chromatography, Liquid; Drug Stability; Fluoxetine; Humans; Linear Models; Male; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Sertraline; Tandem Mass Spectrometry | 2009 |
Antidepressant specificity of serotonin transporter suggested by three LeuT-SSRI structures.
Topics: Amino Acid Transport Systems, Neutral; Antidepressive Agents, Tricyclic; Binding Sites; Cell Line; Crystallography, X-Ray; Dopamine; Drug Evaluation, Preclinical; Fluoxetine; Humans; Models, Chemical; Mutation; Norepinephrine; Protein Binding; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2009 |
Fast separation of selective serotonin reuptake inhibitors antidepressants in plasma sample by nonaqueous capillary electrophoresis.
Topics: Antidepressive Agents; Citalopram; Drug Monitoring; Electrophoresis, Capillary; Fluoxetine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2009 |
Growth and development of tadpoles (Xenopus laevis) exposed to selective serotonin reuptake inhibitors, fluoxetine and sertraline, throughout metamorphosis.
Topics: Abnormalities, Drug-Induced; Animals; Dose-Response Relationship, Drug; Fluoxetine; Larva; Metamorphosis, Biological; Selective Serotonin Reuptake Inhibitors; Sertraline; Water Pollutants, Chemical; Xenopus laevis | 2009 |
Paroxetine inhibited the relaxations induced by EFS in mice corpus cavernosum: is it a NOS inhibition?
Topics: Animals; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Male; Mice; Mice, Inbred BALB C; Muscle Relaxation; Muscle, Smooth; Nitric Oxide; Nitric Oxide Synthase; Paroxetine; Penis; Phenylephrine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Changes in antidepressant metabolism in pregnancy evidenced by metabolic ratios in hair: a novel approach.
Topics: Adult; Antidepressive Agents; Citalopram; Cyclohexanols; Female; Fluoxetine; Gas Chromatography-Mass Spectrometry; Hair; Humans; Postpartum Period; Pregnancy; Pregnancy Trimester, First; Pregnancy Trimester, Third; Sertraline; Venlafaxine Hydrochloride | 2010 |
Deaths involving serotonergic drugs.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Australia; Cause of Death; Citalopram; Cyclohexanols; Female; Fluoxetine; Forensic Toxicology; Gas Chromatography-Mass Spectrometry; Humans; Male; Middle Aged; N-Methyl-3,4-methylenedioxyamphetamine; Paroxetine; Serotonin Agents; Sertraline; Tramadol; Venlafaxine Hydrochloride | 2010 |
Cost-effectiveness analysis of treatments for premenstrual dysphoric disorder.
Topics: Androstenes; Cost of Illness; Cost-Benefit Analysis; Drug Costs; Female; Fluoxetine; Humans; Mineralocorticoid Receptor Antagonists; Models, Economic; Paroxetine; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2010 |
Comparative safety of antidepressant agents for children and adolescents regarding suicidal acts.
Topics: Adolescent; Antidepressive Agents; Child; Citalopram; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Fluoxetine; Fluvoxamine; Humans; Male; Paroxetine; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Suicide; Suicide Prevention; Suicide, Attempted | 2010 |
Sertraline-induced enuresis in a prepubertal child resolves after switching to fluoxetine.
Topics: Child; Enuresis; Fluoxetine; Humans; Male; Obsessive-Compulsive Disorder; Selective Serotonin Reuptake Inhibitors; Sertraline | 2010 |
Atypical anti-psychotics in delusional parasitosis: a retrospective case series of 20 patients.
Topics: Antipsychotic Agents; Benzodiazepines; Ectoparasitic Infestations; Female; Fluoxetine; Haloperidol; Humans; Imipramine; Male; Middle Aged; Olanzapine; Pimozide; Retrospective Studies; Risperidone; Schizophrenia, Paranoid; Sertraline | 2010 |
Onset of catatonia at puberty: electroconvulsive therapy response in two autistic adolescents.
Topics: Adolescent; Age of Onset; Aggression; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Autistic Disorder; Catatonia; Child; Child Development Disorders, Pervasive; Education, Special; Electroconvulsive Therapy; Electroencephalography; Fluoxetine; Hearing Loss, Sensorineural; Humans; Intellectual Disability; Magnetic Resonance Imaging; Male; Puberty; Sertraline; Sports; Stereotyped Behavior | 2010 |
An audit to compare discharge rates between antidepressant monotherapies prescribed for pure unipolar depression versus depression in the presence of other indications.
Topics: Adult; Antidepressive Agents; Citalopram; Community Mental Health Centers; Comorbidity; Cyclohexanols; Depressive Disorder; England; Fluoxetine; Guideline Adherence; Humans; Medical Audit; Mianserin; Mirtazapine; Patient Discharge; Practice Patterns, Physicians'; Sertraline; Suicide; Suicide Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
Effect of SSRI antidepressants on L-thyroxine requirements.
Topics: Antidepressive Agents; Drug Administration Schedule; Fluoxetine; Humans; Hypothyroidism; Selective Serotonin Reuptake Inhibitors; Sertraline; Thyroid Hormones; Thyroxine | 2010 |
Environmental risk assessment of three selective serotonin reuptake inhibitors in the aquatic environment: a case study including a cocktail scenario.
Topics: Biodegradation, Environmental; Citalopram; Environmental Monitoring; Fluoxetine; Fresh Water; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Sewage; Waste Disposal, Fluid; Water Pollutants, Chemical | 2011 |
Do early changes in the HAM-D-17 anxiety/somatization factor items affect the treatment outcome among depressed outpatients? Comparison of two controlled trials of St John's wort (Hypericum perforatum) versus a SSRI.
Topics: Depressive Disorder, Major; Fluoxetine; Humans; Hypericum; Logistic Models; Outpatients; Phytotherapy; Plant Preparations; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Remission Induction; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2011 |
Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows.
Topics: Animals; Antidepressive Agents; Brain; Bupropion; Cyclohexanols; Cyprinidae; Endocrine Disruptors; Female; Fluoxetine; Male; Reproduction; Sertraline; Testis; Venlafaxine Hydrochloride; Vitellogenins; Water Pollutants, Chemical | 2011 |
Antidepressant use during pregnancy. FPIN’s clinical inquiries.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Evidence-Based Medicine; Female; Fluoxetine; Humans; Odds Ratio; Paroxetine; Physicians, Family; Pregnancy; Pregnancy Complications; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2011 |
Selective siRNA-mediated suppression of 5-HT1A autoreceptors evokes strong anti-depressant-like effects.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Administration, Intranasal; Animals; Antidepressive Agents; Autoreceptors; Depression; Disease Models, Animal; Drug Combinations; Drug Design; Fluoxetine; Hippocampus; Hypothermia; Infusions, Intraventricular; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Prefrontal Cortex; Receptor, Serotonin, 5-HT1A; RNA, Small Interfering; Serotonergic Neurons; Sertraline | 2012 |
Pulmonary vascular effects of serotonin and selective serotonin reuptake inhibitors in the late-gestation ovine fetus.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Dose-Response Relationship, Drug; Female; Fetus; Fluoxetine; Hemodynamics; Hypertension, Pulmonary; Hysterotomy; Indoles; Ketanserin; Lung; Oxadiazoles; Piperazines; Pregnancy; Pulmonary Artery; Pyridines; Receptors, Serotonin; rho-Associated Kinases; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin 5-HT2 Receptor Antagonists; Sertraline; Sheep; Vascular Resistance | 2011 |
Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction.
Topics: Adrenal Cortex Hormones; Age Factors; Aged; Anemia; Angioplasty; Anticoagulants; Antihypertensive Agents; Aspirin; Canada; Citalopram; Clopidogrel; Cohort Studies; Drug Therapy, Combination; Female; Fluoxetine; Fluvoxamine; Heart Failure; Hemorrhage; Humans; Hypoglycemic Agents; Male; Middle Aged; Myocardial Infarction; Neoplasms; Paroxetine; Peptic Ulcer; Platelet Aggregation Inhibitors; Renal Insufficiency; Retrospective Studies; Risk; Risk Factors; Secondary Prevention; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Ticlopidine | 2011 |
The MMPI-2 neurotic triad subscales and depression levels after pharmacological treatment in patients with depressive disorders - clinical study.
Topics: Adult; Antidepressive Agents; Citalopram; Depressive Disorder; Female; Fluoxetine; Humans; Hypochondriasis; Hysteria; Male; Middle Aged; MMPI; Neurotic Disorders; Observer Variation; Paroxetine; Psychometrics; Reproducibility of Results; Sertraline; Statistics as Topic; Young Adult | 2011 |
Treatment practices in Tourette syndrome: the European perspective.
Topics: Adult; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Clonidine; Depression; Europe; Fluoxetine; Fluvoxamine; Health Care Surveys; Humans; Methylphenidate; Obsessive-Compulsive Disorder; Physicians; Piperazines; Propylamines; Psychiatry; Quinolones; Risperidone; Sertraline; Sulpiride; Tourette Syndrome | 2012 |
Ferulic acid exerts antidepressant-like effect in the tail suspension test in mice: evidence for the involvement of the serotonergic system.
Topics: Animals; Antidepressive Agents; Coumaric Acids; Dose-Response Relationship, Drug; Drug Interactions; Fluoxetine; Immobility Response, Tonic; Ketanserin; Male; Mice; Motor Activity; Paroxetine; Piperazines; Pyridines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT1 Receptor Antagonists; Serotonin 5-HT2 Receptor Antagonists; Sertraline | 2012 |
High venlafaxine serum levels after prior fluoxetine medication.
Topics: Antidepressive Agents, Second-Generation; Cholinergic Antagonists; Cyclohexanols; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder; Female; Fluoxetine; Humans; Male; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2012 |
Global gene expression in larval zebrafish (Danio rerio) exposed to selective serotonin reuptake inhibitors (fluoxetine and sertraline) reveals unique expression profiles and potential biomarkers of exposure.
Topics: Animals; Biomarkers; Fluoxetine; Gene Expression; Larva; Selective Serotonin Reuptake Inhibitors; Sertraline; Water Pollutants, Chemical; Zebrafish; Zebrafish Proteins | 2012 |
Comparison of two extraction methods for the determination of selective serotonin reuptake inhibitors in sewage sludge by hollow fiber liquid-phase microextraction.
Topics: Chromatography, Liquid; Citalopram; Fluoxetine; Liquid Phase Microextraction; Mass Spectrometry; Paroxetine; Porosity; Selective Serotonin Reuptake Inhibitors; Sertraline; Sewage; Surface Properties | 2012 |
Serotonin transporter genotype and function in relation to antidepressant response in Koreans.
Topics: Adult; Aged; Asian People; Blood Platelets; Case-Control Studies; Depressive Disorder, Major; Female; Fluoxetine; Genotype; Humans; Male; Middle Aged; Polymorphism, Genetic; Promoter Regions, Genetic; Republic of Korea; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Treatment Outcome | 2013 |
Effect of fluoxetine and adenosine receptor NECA agonist on G alpha q/11 protein of C6 glioma cells.
Topics: Adenosine-5'-(N-ethylcarboxamide); Animals; Brain Neoplasms; Cell Line, Tumor; Citalopram; Depression; Fluoxetine; Glioma; GTP-Binding Protein alpha Subunits, Gq-G11; Neurons; Purinergic P1 Receptor Agonists; Rats; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction | 2012 |
[The comparative study on the efficacy of the combination of serotonin reuptake inhibitor antidepressants and antipsychotics in the treatment of recurrent depressive disorders].
Topics: Adolescent; Adult; Amisulpride; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Depressive Disorder; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Olanzapine; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Sulpiride; Treatment Outcome; Young Adult | 2012 |
Selective serotonin reuptake inhibitors (SSRIs) inhibit insulin secretion and action in pancreatic β cells.
Topics: Animals; Apoptosis; Cell Death; Cell Line; Diabetes Mellitus; Fluoxetine; Humans; Insulin; Insulin Receptor Substrate Proteins; Insulin Resistance; Insulin-Secreting Cells; Male; Mice; Mice, Inbred C57BL; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction; Unfolded Protein Response | 2013 |
Effects of sertraline and fluoxetine on p-glycoprotein at barrier sites: in vivo and in vitro approaches.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Blood-Brain Barrier; Blood-Testis Barrier; Endothelial Cells; Fluoxetine; Guinea Pigs; Male; Mice; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors | 2013 |
A pooled analysis of six month comparative efficacy and tolerability in four randomized clinical trials: agomelatine versus escitalopram, fluoxetine, and sertraline.
Topics: Acetamides; Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Citalopram; Depressive Disorder; Depressive Disorder, Major; Female; Fluoxetine; Humans; Hypnotics and Sedatives; Male; Middle Aged; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Sertraline; Treatment Outcome; Young Adult | 2013 |
The pharmacoepidemiology of selective serotonin reuptake inhibitors for children and adolescents in Canada from 2005 to 2009: a database analysis.
Topics: Adolescent; Anti-Anxiety Agents; Antidepressive Agents; Canada; Child; Child, Preschool; Citalopram; Databases, Factual; Fluoxetine; Fluvoxamine; Humans; Infant; Mental Disorders; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Sertraline | 2013 |
The effect of antidepressant drugs on thioacetamide-induced oxidative stress.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Antidepressive Agents; Aspartate Aminotransferases; Brain; Female; Fluoxetine; Glutathione; Liver; Male; Malondialdehyde; Nitric Oxide; Oxidative Stress; Rats; Rats, Sprague-Dawley; Sertraline; Thioacetamide | 2013 |
Parallel electromembrane extraction in a multiwell plate.
Topics: Amitriptyline; Antipsychotic Agents; Calibration; Chromatography, Liquid; Dibenzothiazepines; Electrochemical Techniques; Ethers; Fluoxetine; Humans; Limit of Detection; Membranes, Artificial; Quetiapine Fumarate; Sertraline; Solid Phase Extraction; Tandem Mass Spectrometry; Time Factors | 2014 |
Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Enlargement; Cells, Cultured; Citalopram; Dendrites; Fluoxetine; Hippocampus; Imipramine; Nerve Tissue Proteins; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Sertraline; Thiazepines; Tranylcypromine | 2014 |
Behavioural and transcriptional changes in the amphipod Echinogammarus marinus exposed to two antidepressants, fluoxetine and sertraline.
Topics: Amphipoda; Animals; Behavior, Animal; Environmental Exposure; Fluoxetine; Gene Expression Regulation; Motor Activity; Sertraline; Water Pollutants, Chemical | 2014 |
Editorial Comment from Dr Sato to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Editorial Comment from Dr Amano to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Response to Editorial Comments to Relationship between plasma melatonin levels and the efficacy of selective serotonin reuptake inhibitors treatment on premature ejaculation.
Topics: Fluoxetine; Humans; Male; Melatonin; Paroxetine; Premature Ejaculation; Selective Serotonin Reuptake Inhibitors; Sertraline | 2014 |
Effects of acute administration of selective serotonin reuptake inhibitors on sympathetic nerve activity.
Topics: Animals; Antidepressive Agents; Arterial Pressure; Baroreflex; Cardiovascular Physiological Phenomena; Fluoxetine; Heart Rate; Kidney; Male; Paroxetine; Rats, Wistar; Respiratory Rate; Selective Serotonin Reuptake Inhibitors; Sertraline; Sympathetic Nervous System; Vital Signs | 2014 |
Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Topics: Administration, Oral; Adolescent; Aripiprazole; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Delayed-Action Preparations; Dose-Response Relationship, Drug; Drug Interactions; Female; Fluoxetine; Humans; Male; Methylphenidate; Retrospective Studies; Risperidone; Sertraline | 2015 |
Prophylactic efficacy of fluoxetine, escitalopram, sertraline, paroxetine, and concomitant psychotherapy in major depressive disorder: outcome after long-term follow-up.
Topics: Adult; Citalopram; Cognitive Behavioral Therapy; Cohort Studies; Combined Modality Therapy; Depressive Disorder, Major; Female; Fluoxetine; Follow-Up Studies; Humans; Long-Term Care; Male; Middle Aged; Paroxetine; Prospective Studies; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Therapeutic Drug Monitoring of Selective Serotonin Reuptake Inhibitors in Elderly Patients.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Child; Citalopram; Databases, Factual; Drug Monitoring; Drug Utilization; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Norway; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2015 |
Real-world outcomes in patients with depression treated with duloxetine or a selective serotonin reuptake inhibitor in East Asia.
Topics: Adult; Asia, Eastern; Citalopram; Depressive Disorder, Major; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Middle Aged; Pain; Paroxetine; Prospective Studies; Quality of Life; Regression Analysis; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Severity of Illness Index; Treatment Outcome | 2016 |
Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials.
Topics: Adult; Amitriptyline; Antidepressive Agents; Bupropion; Citalopram; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Evidence-Based Medicine; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Moclobemide; Nortriptyline; Paroxetine; Randomized Controlled Trials as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2015 |
Therapeutic antidepressant potential of a conjugated siRNA silencing the serotonin transporter after intranasal administration.
Topics: Administration, Intranasal; Animals; Antidepressive Agents; Arabidopsis Proteins; Brain; Corticosterone; Depression; Disease Models, Animal; DNA, Antisense; Endocytosis; Exploratory Behavior; Fluoxetine; Gene Expression Regulation; Intramolecular Transferases; Male; Mice; Mice, Inbred C57BL; Neurons; Phosphopyruvate Hydratase; RNA, Small Interfering; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline; Time Factors | 2016 |
Effects of selective serotonin reuptake inhibitors on three sex steroids in two versions of the aromatase enzyme inhibition assay and in the H295R cell assay.
Topics: Aromatase; Aromatase Inhibitors; Cell Line, Tumor; Citalopram; Estradiol; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Progesterone; Selective Serotonin Reuptake Inhibitors; Sertraline; Testosterone | 2015 |
Studies regarding the protective effects exhibited by antidepressants on cell models.
Topics: Antidepressive Agents; Antioxidants; Cell Membrane; Depressive Disorder; Dose-Response Relationship, Drug; Erythrocytes; Female; Fluoxetine; Glucosephosphate Dehydrogenase; Humans; Immune System; Lipid Peroxidation; Middle Aged; Oxidative Stress; Sertraline; U937 Cells; Venlafaxine Hydrochloride | 2015 |
Dosing of Selective Serotonin Reuptake Inhibitors Among Children and Adults Before and After the FDA Black-Box Warning.
Topics: Adolescent; Adult; Antidepressive Agents; Child; Child, Preschool; Citalopram; Cohort Studies; Databases, Factual; Depression; Dose-Response Relationship, Drug; Drug Labeling; Drug Prescriptions; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Practice Guidelines as Topic; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Suicide, Attempted; United States; United States Food and Drug Administration; Young Adult | 2016 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
Differential Associations of Specific Selective Serotonin Reuptake Inhibitors With Resting-State Heart Rate and Heart Rate Variability: Implications for Health and Well-Being.
Topics: Adult; Aged; Brazil; Citalopram; Electrocardiography; Female; Fluoxetine; Heart Rate; Humans; Male; Middle Aged; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Selective serotonin reuptake inhibitor exposure constricts the mouse ductus arteriosus in utero.
Topics: Animals; Aorta; Ductus Arteriosus; Female; Fluoxetine; Immunohistochemistry; Mice; Myography; Persistent Fetal Circulation Syndrome; Pregnancy; Real-Time Polymerase Chain Reaction; Receptors, Serotonin; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Sertraline; Vasoconstriction | 2016 |
Which SSRIs most effectively treat depression in adolescents?
Topics: Adolescent; Adolescent Behavior; Antidepressive Agents; Behavior Therapy; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Risk Assessment; Selective Serotonin Reuptake Inhibitors; Sertraline | 2016 |
Bioaccumulation and trophodynamics of the antidepressants sertraline and fluoxetine in laboratory-constructed, 3-level aquatic food chains.
Topics: Animals; Antidepressive Agents; Aquatic Organisms; Fluoxetine; Food Chain; Models, Theoretical; Sertraline; Sweden; Water Pollutants, Chemical | 2017 |
Exposure to SSRI-type antidepressants increases righting time in the marine snail Ilyanassa obsoleta.
Topics: Animals; Antidepressive Agents; Fluoxetine; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Snails; Venlafaxine Hydrochloride | 2017 |
Effect of antidepressants on circadian rhythms in fish: Insights and implications regarding the design of behavioural toxicity tests.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Circadian Rhythm; Cyprinodontiformes; Fluoxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Toxicity Tests; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2017 |
Inhibition of the Serotonin Transporter Is Altered by Metabolites of Selective Serotonin and Norepinephrine Reuptake Inhibitors and Represents a Caution to Acute or Chronic Treatment Paradigms.
Topics: Animals; Citalopram; Fluoxetine; Mice; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline; Synaptosomes | 2017 |
Subcellular Partitioning and Intramacrophage Selectivity of Antimicrobial Compounds against Mycobacterium tuberculosis.
Topics: Ammonium Chloride; Anesthetics, Local; Antitubercular Agents; Biological Transport; Clofazimine; Dibucaine; Fluoxetine; Humans; Hydrogen-Ion Concentration; Macrolides; Macrophages; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Protons; Selective Serotonin Reuptake Inhibitors; Sertraline | 2017 |
A Case of Fluoxetine-Induced Lower Extremity Ecchymosis.
Topics: Adult; Antidepressive Agents, Second-Generation; Cytochrome P-450 CYP2D6 Inhibitors; Depressive Disorder, Major; Drug Substitution; Ecchymosis; Female; Fluoxetine; Humans; Lower Extremity; Sertraline | 2017 |
Antidepressants are cytotoxic to rat primary blood brain barrier endothelial cells at high therapeutic concentrations.
Topics: Animals; Antidepressive Agents; Blood-Brain Barrier; Cell Survival; Cells, Cultured; Clomipramine; Endothelial Cells; Energy Metabolism; Fluoxetine; Glutathione; Lactic Acid; Male; Membrane Potential, Mitochondrial; Oxidative Stress; Oxygen Consumption; Rats; Reactive Oxygen Species; Sertraline | 2017 |
[Exploring the clinical characters of Shugan Jieyu capsule through text mining].
Topics: Anxiety; Data Mining; Depression; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Fluoxetine; Humans; Paroxetine; Sertraline | 2017 |
Joint effects of nine antidepressants on Raphidocelis subcapitata and Skeletonema marinoi: A matter of amine functional groups.
Topics: Amines; Antidepressive Agents; Chlorophyta; Diatoms; Fluoxetine; Sertraline; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2018 |
Anti-Candida activity of antidepressants sertraline and fluoxetine: effect upon pre-formed biofilms.
Topics: Antidepressive Agents; Antifungal Agents; Biofilms; Candida; Drug Repositioning; Fluoxetine; Formazans; Gentian Violet; Humans; Microbial Sensitivity Tests; Microbial Viability; Sertraline; Staining and Labeling; Tetrazolium Salts; Thiazoles | 2018 |
Hypobaric hypoxia exposure in rats differentially alters antidepressant efficacy of the selective serotonin reuptake inhibitors fluoxetine, paroxetine, escitalopram and sertraline.
Topics: Altitude Sickness; Animals; Antidepressive Agents; Brain; Citalopram; Dopamine; Female; Fluoxetine; Male; Paroxetine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2018 |
Association of Antidepressant Use With Drug-Related Extrapyramidal Symptoms: A Pharmacoepidemiological Study.
Topics: Antidepressive Agents; Basal Ganglia Diseases; Bupropion; Case-Control Studies; Citalopram; Duloxetine Hydrochloride; Female; Fluoxetine; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Paroxetine; Pharmacoepidemiology; Sertraline; United States; Venlafaxine Hydrochloride | 2018 |
Topics: Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line; Citalopram; Epithelial Cells; Fluoxetine; Paroxetine; Pharmacogenomic Variants; Polymorphism, Single Nucleotide; Sertraline; Swine | 2018 |
A Retrospective Comparative Effectiveness Study of Medications for Posttraumatic Stress Disorder in Routine Practice.
Topics: Adult; Anticonvulsants; Female; Fluoxetine; Humans; Male; Medical Records; Middle Aged; Outpatients; Paroxetine; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; Treatment Outcome; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2018 |
Effects of selective serotonin-reuptake inhibitors (SSRIs) in JEG-3 and HIPEC cell models of the extravillous trophoblast.
Topics: ADAM10 Protein; Amyloid Precursor Protein Secretases; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Choriocarcinoma; Female; Fluoxetine; Gene Expression; Humans; Matrix Metalloproteinase 9; Membrane Proteins; Models, Biological; Pregnancy; RNA, Messenger; Selective Serotonin Reuptake Inhibitors; Sertraline; Tissue Inhibitor of Metalloproteinase-1; Trophoblasts; Venlafaxine Hydrochloride | 2018 |
A functional variant in the serotonin receptor 7 gene (HTR7), rs7905446, is associated with good response to SSRIs in bipolar and unipolar depression.
Topics: Adult; Aged; Aged, 80 and over; Animals; Citalopram; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Middle Aged; Paroxetine; Receptors, Serotonin; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult | 2020 |
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Topics: Age Factors; Aged; Aged, 80 and over; Cardiac Conduction System Disease; Citalopram; Death, Sudden, Cardiac; Depression; Electrocardiography; Female; Fluoxetine; Fluvoxamine; Humans; Kidney Failure, Chronic; Male; Middle Aged; Peroxidase; Registries; Renal Dialysis; Retrospective Studies; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; United States | 2019 |
An In Vitro Study of Aromatic Stacking of Drug Molecules.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Antineoplastic Agents, Phytogenic; Binding Sites; Diazepam; Drug Interactions; Fluoxetine; Haloperidol; Humans; Models, Molecular; Paclitaxel; Sertraline; Spectrometry, Mass, Electrospray Ionization | 2019 |
In-vitro and in situ assessment of the efflux of five antidepressants by breast cancer resistance protein.
Topics: Amitriptyline; Animals; Antidepressive Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Biological Transport; Blood-Brain Barrier; Brain; Cell Line, Tumor; Duloxetine Hydrochloride; Fluoxetine; Humans; Mirtazapine; Neoplasm Proteins; Rats; Rats, Sprague-Dawley; Sertraline | 2019 |
Influence of baseline severity on the effects of SSRIs in depression: an item-based, patient-level post-hoc analysis.
Topics: Antidepressive Agents; Citalopram; Clinical Trials as Topic; Depression; Depressive Disorder, Major; Fluoxetine; Humans; Longitudinal Studies; Outcome Assessment, Health Care; Paroxetine; Placebos; Psychiatric Status Rating Scales; Reproducibility of Results; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index | 2019 |
Model Placental Barrier Phenotypic Response to Fluoxetine and Sertraline: A Comparative Study.
Topics: Cell Membrane Permeability; Extracellular Matrix; Female; Fluoxetine; Human Umbilical Vein Endothelial Cells; Humans; Models, Biological; Phenotype; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Transforming Growth Factor beta; Trophoblasts | 2019 |
MicroRNA profiling identifies a novel compound with antidepressant properties.
Topics: Animals; Antidepressive Agents; Brain Injuries, Traumatic; Computational Biology; Depression; Disease Models, Animal; Estradiol; Fluoxetine; Gene Expression Regulation; Hippocampus; Humans; Imipramine; MicroRNAs; Rats; Sertraline; Sulfonamides; Thiazoles | 2019 |
Analysis of neurotransmitters in Daphnia magna affected by neuroactive pharmaceuticals using liquid chromatography-high resolution mass spectrometry.
Topics: Animals; Aquatic Organisms; Chromatography, High Pressure Liquid; Daphnia; Duloxetine Hydrochloride; Fluoxetine; Mass Spectrometry; Models, Animal; Neurotransmitter Agents; Sertraline; Venlafaxine Hydrochloride; Water Pollutants, Chemical | 2019 |
Storage of urine specimens in point of care (POC) urine drug testing cups reduces concentrations of many drugs.
Topics: Amitriptyline; Chromatography, Liquid; Drug Storage; Fentanyl; Flunitrazepam; Fluoxetine; Humans; Mass Spectrometry; Nortriptyline; Paroxetine; Point-of-Care Testing; Sertraline | 2019 |
Serotonin and serotonin reuptake inhibitors alter placental aromatase.
Topics: Aromatase; Cells, Cultured; Citalopram; Female; Fluoxetine; Humans; Molecular Docking Simulation; Paroxetine; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Trophoblasts; Venlafaxine Hydrochloride | 2019 |
Assessing SSRIs' effects on fetal cardiomyocytes utilizing placenta-fetus model.
Topics: Animals; Biomarkers; Calcium; Coculture Techniques; Creatine Kinase, MB Form; Female; Fetus; Fluoxetine; Human Umbilical Vein Endothelial Cells; Humans; Induced Pluripotent Stem Cells; Myocardium; Myocytes, Cardiac; Natriuretic Peptide, Brain; Oscillometry; Peptide Fragments; Placenta; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline; Signal Transduction; Trophoblasts; Troponin T | 2019 |
Fluoxetine and sertraline effects on rat distal cauda epididymis contraction, sperm count and sperm transit time trough epididymis.
Topics: Animals; Antidepressive Agents; Epididymis; Fluoxetine; Male; Rats, Wistar; Sertraline; Sperm Count; Sperm Motility; Spermatozoa | 2019 |
The Molecular and Enzyme Kinetic Basis for Altered Activity of Three Cytochrome P450 2C19 Variants Found in the Chinese Population.
Topics: Alleles; Amino Acid Sequence; Asian People; Catalytic Domain; Coumarins; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C19 Inhibitors; Fluoxetine; Humans; Ketoconazole; Kinetics; Loratadine; Models, Molecular; Molecular Docking Simulation; Mutagenesis, Site-Directed; Nitriles; Omeprazole; Polymorphism, Genetic; Protein Conformation; Protein Isoforms; Recombinant Proteins; Sertraline; Substrate Specificity | 2020 |
Two antidepressants fluoxetine and sertraline cause growth retardation and oxidative stress in the marine rotifer Brachionus koreanus.
Topics: Animals; Antidepressive Agents; Antioxidants; Fluoxetine; Glutathione; Glutathione Transferase; Life Cycle Stages; Oxidative Stress; Reactive Oxygen Species; Rotifera; Sertraline; Water Pollutants, Chemical | 2020 |
Antidepressant treatment strategy with an early onset of action improves the clinical outcome in patients with major depressive disorder and high anxiety: a multicenter and 6-week follow-up study.
Topics: Antidepressive Agents; Anxiety; Citalopram; Depressive Disorder, Major; Fluoxetine; Fluvoxamine; Follow-Up Studies; Humans; Least-Squares Analysis; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome | 2020 |
Selective Inhibition of the Serotonin Transporter in the Treatment of Depression: Sertraline, Fluoxetine and Citalopram.
Topics: Citalopram; Depression; Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2020 |
Evidence-based prescribing for post-traumatic stress disorder.
Topics: Evidence-Based Medicine; Fluoxetine; Humans; Paroxetine; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2020 |
THE SELECTIVE SEROTONIN REUPTAKE INHIBITORS AND BEHAVIOUR OF ADULT DANIO RERIO IN EXPERIMENTS.
Topics: Animals; Fluoxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming; Zebrafish | 2020 |
Comparing Medications for DSM-5 PTSD in Routine VA Practice.
Topics: Acute Disease; Adult; Carbonic Anhydrase Inhibitors; Female; Fluoxetine; Humans; Male; Medication Adherence; Outcome Assessment, Health Care; Paroxetine; Remission Induction; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Topiramate; United States; United States Department of Veterans Affairs; Venlafaxine Hydrochloride | 2020 |
Urinary selective serotonin reuptake inhibitors across critical windows of pregnancy establishment: a prospective cohort study of fecundability and pregnancy loss.
Topics: Abortion, Spontaneous; Adult; Citalopram; Female; Fertility; Fluoxetine; Humans; Live Birth; Pregnancy; Pregnancy Trimester, First; Prospective Studies; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Selective Serotonin Reuptake Inhibitors; Sertraline; Time Factors; United States; Young Adult | 2020 |
Low SSRI dosing in clinical practice-a register-based longitudinal study.
Topics: Child; Citalopram; Fluoxetine; Humans; Longitudinal Studies; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2021 |
Topics: Adolescent; Anxiety Disorders; Fluoxetine; Humans; Meta-Analysis as Topic; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Wake Disorders | 2021 |
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study.
Topics: Antidepressive Agents; Bupropion; Citalopram; Duloxetine Hydrochloride; Escitalopram; Female; Fluoxetine; Humans; Infant, Newborn; Pregnancy; Prenatal Exposure Delayed Effects; Retrospective Studies; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride | 2021 |
Fluoxetine and sertraline based multitarget inhibitors of cholinesterases and monoamine oxidase-A/B for the treatment of Alzheimer's disease: Synthesis, pharmacology and molecular modeling studies.
Topics: Alzheimer Disease; Animals; Cholinesterase Inhibitors; Drug Design; Fluoxetine; Humans; Mice; Monoamine Oxidase Inhibitors; Sertraline; Structure-Activity Relationship | 2021 |
Antidepressant medication prescribing patterns in Irish general practice from 2016 to 2020 to assess for long-term use.
Topics: Antidepressive Agents; Drug Prescriptions; Fluoxetine; General Practice; Humans; Practice Patterns, Physicians'; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride | 2022 |
Mortality Risk Among Patients With COVID-19 Prescribed Selective Serotonin Reuptake Inhibitor Antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Citalopram; COVID-19; Cytokines; Female; Fluoxetine; Fluvoxamine; Humans; Male; Middle Aged; Prescription Drugs; Retrospective Studies; Risk; SARS-CoV-2; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; United States | 2021 |
Peripartal treatment with low-dose sertraline accelerates mammary gland involution and has minimal effects on maternal and offspring bone.
Topics: Animals; Calcium; Female; Fluoxetine; Humans; Lactation; Mammary Glands, Human; Mice; Mice, Inbred C57BL; Osteogenesis; Pregnancy; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
The effects of antidepressants fluoxetine, sertraline, and amitriptyline on the development of antibiotic resistance in Acinetobacter baumannii.
Topics: Acinetobacter baumannii; Amitriptyline; Antidepressive Agents; Drug Resistance, Multiple, Bacterial; Fluoxetine; Humans; Sertraline | 2022 |
Antidepressants Are Poor Inhibitors of Heat-Evoked Ion Currents Mediated by TRPM2.
Topics: Adenosine Diphosphate Ribose; Amitriptyline; Animals; Antidepressive Agents; Citalopram; Duloxetine Hydrochloride; Fluoxetine; HEK293 Cells; Hot Temperature; Humans; Ketamine; Lidocaine; Mice; Paroxetine; Pregabalin; Sertraline; TRPM Cation Channels | 2022 |
Effects of central nervous system drugs on androgen, estrogen α, glucocorticoid, and thyroid receptors.
Topics: Androgens; Animals; Carbamazepine; Central Nervous System Agents; CHO Cells; Clonazepam; Cricetinae; Cricetulus; Estrogen Receptor alpha; Estrogens; Fluoxetine; Glucocorticoids; Luciferases, Firefly; Paroxetine; Receptors, Androgen; Receptors, Glucocorticoid; Sertraline; Thyroid Gland | 2022 |
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
Topics: Case-Control Studies; Citalopram; Cohort Studies; Death, Sudden, Cardiac; Dialysis Solutions; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Potassium; Renal Dialysis; Selective Serotonin Reuptake Inhibitors; Sertraline; United States | 2022 |
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Paroxetine; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain | 2022 |
Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths.
Topics: Adolescent; Antipsychotic Agents; Citalopram; Diabetes Mellitus, Type 2; Fluoxetine; Fluvoxamine; Humans; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Sertraline | 2022 |
Rapid-Onset Nonallergic Peripheral Edema With Sertraline and Fluoxetine in the Postpartum Period.
Topics: Edema; Female; Fluoxetine; Humans; Postpartum Period; Selective Serotonin Reuptake Inhibitors; Sertraline | 2022 |
Combination of Antimalarial and CNS Drugs with Antineoplastic Agents in MCF-7 Breast and HT-29 Colon Cancer Cells: Biosafety Evaluation and Mechanism of Action.
Topics: Adenosine Diphosphate; Antimalarials; Antineoplastic Agents; Artesunate; ATP Binding Cassette Transporter, Subfamily B, Member 1; Benztropine; Breast Neoplasms; Cell Line, Tumor; Chloroquine; Colonic Neoplasms; Containment of Biohazards; Doxorubicin; Drug Resistance, Neoplasm; Female; Fluorouracil; Fluoxetine; Fluphenazine; Humans; Ki-67 Antigen; MCF-7 Cells; Michigan; NF-kappa B; Paclitaxel; Poly(ADP-ribose) Polymerase Inhibitors; Ribose; Sertraline; Thioridazine | 2022 |
Contrasting dose response relationships of neuroactive antidepressants on the behavior of C. elegans.
Topics: Acetylcholinesterase; Animals; Antidepressive Agents; Caenorhabditis elegans; Chlorpyrifos; Fluoxetine; Selective Serotonin Reuptake Inhibitors; Sertraline | 2023 |
Synergistic anti-depressive effect of combination treatment of Brexpiprazole and selective serotonin reuptake inhibitors on forced swimming test in mice.
Topics: Animals; Antidepressive Agents; Depressive Disorder, Major; Escitalopram; Fluoxetine; Mice; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Swimming | 2023 |
Posttraumatic Stress Disorder: Evaluation and Treatment.
Topics: Fluoxetine; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2023 |
FKBP5 blockade may provide a new horizon for the treatment of stress-associated disorders: An in-silico study.
Topics: Citalopram; Clomipramine; Duloxetine Hydrochloride; Fluoxetine; Humans; Sertraline; United States | 2023 |